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ABSTRACT 
 
Purification and Characterization of a Recombinant Glycoprotein, Canine Thyroid 
Stimulating Hormone, as a Prelude to the Development of the Reproductive 
Glycoproteins. (August 2012) 
Malcolm Leihulu Delovio, Jr., B.S., Texas A&M University 
Co-Chairs of Advisory Committee: Dr. Scott Jaques 
 Dr. David Forrest 
 
 A baculovirus (Spodoptera frugiperda) system was designed to express 
recombinant canine thyroid stimulating hormone (rcTSH).  The efficacy of rcTSH was 
measured against pituitary derived bovine thyroid stimulating hormone (bTSH) through 
a series of in vitro and in vivo experiments. 
 Initial purification of rcTSH was performed in order to characterize the hormone 
for further analyses.  Ion exchange columns and tangential flow membranes were chosen 
based upon the traits of the rcTSH molecule.  Sodium dodecyl sulfate polyacrylamide 
gel electrophoresis (SDS-PAGE) gels visualized by Coomassie blue, silver stain, and 
western blot demonstrated the effectiveness of the purification process. 
 Primary cell, static tissue, and perifusion tissue cultures were employed to 
investigate in vitro thyroid cell/tissue response to rcTSH and bTSH.  Canine thyroid 
cells were liberated from tissue samples, cultured, then exposed to TSH treatments in 
which media was subsequently harvested and measured for cyclic adenosine 
monophosphate (cAMP), a second messenger in the TSH downstream signaling cascade.  
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The cAMP concentrations measured were sporadic and not consistent with expected 
concentrations for treatments or controls.  For the static tissue culture, slices of bovine 
thyroid tissue were incubated and exposed to a series of media-only wash steps as well 
as treatment steps using varying concentrations of rcTSH.  Unfortunately, the 
experiment was compromised resulting in the slow release of thyroxine (T4) for all 
samples due to tissue death.  Perifusion experiments conducted on bovine thyroid tissue 
compared the release of T4 due to bTSH and rcTSH stimulation in a dynamic system.  
Unable to perform statistical analysis due to small sample sizes, graphical representation 
demonstrated stimulatory effects by bTSH and rcTSH when compared to control. 
 Biological assays were used to compare the in vivo efficacy of rcTSH to bTSH 
which included 3 species (goldfish, rat, and canine).  Results from mammalian 
experiments when subjected to analysis of variance (ANOVA) resulted in the rejection 
of the null hypothesis of equal means (P<0.05) between control, bTSH, and rcTSH 
treatments.  Further analysis by Tukey’s W procedure demonstrated the stimulatory 
actions of rcTSH and bTSH to be similar (P>0.05) to each other while greater (P<0.05) 
than control at the 4 and 6 hour post injection time. 
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CHAPTER I 
INTRODUCTION AND LITERATURE REVIEW 
 
 In September 1927, researchers discovered a substance produced by the anterior 
pituitary which stimulated thyroid activity inducing metamorphosis in larval 
salamanders (Uhlenhuth and Schwartzbach, 1927).  The substance was thyroid 
stimulating hormone (TSH), a glycoprotein produced and released by the thyrotropes of 
the anterior pituitary.  Secretion of TSH is stimulated when thyrotropin releasing 
hormone (TRH) produced by the medial neurons of the paraventricular nuclei are 
released and traverse the hypothalamic-hypophyseal portal system and bind to its 
receptors on the pituitary thyrotropes.  In the human species, TSH will travel via venous 
drainage from the anterior pituitary to the cavernous sinus leading to the inferior and 
superior petrosal sinus and enter systemic circulation through the superior bulb of the 
jugular vein.  Binding will eventually occur to TSH receptors of follicular cells located 
in the thyroid gland after returning from systemic circulation through one of the three 
following thyroid supply arteries: superior thyroid artery (common carotid), inferior 
thyroid artery (subclavian), or small thyroid ima artery (brachiocephalic at the aortic 
arch) (Greenspan and Baxter, 1994).  This, in turn, will stimulate the production and 
release of triiodothyronine (T3) and T4 from the thyroid gland which are necessary for 
numerous cell activities (i.e. metabolism, protein expression). 
____________ 
This dissertation follows the style of Journal of Animal Science. 
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 The TSH molecule is a heterodimer produced by the thyrotropes of the anterior 
pituitary (adenohypophysis) comprised of an alpha (α) and a beta (β) subunit which are 
non-covalently bound to one another.  The α subunit is conserved among TSH and three 
other glycoprotein hormones within the same species: luteinizing hormone (LH), follicle 
stimulating hormone (FSH) and chorionic gonadotropin (CG).  While FSH and LH are 
produced by the gonadotropes of the anterior pituitary, CG production occurs in the 
placenta during pregnancy.  It is the variations in the β subunit that confer specificity of 
the aforementioned glycoprotein hormones (Keel and Grotjan, 1989).  In the canine, the 
common α subunit consists of 96 amino acids with five intramolecular disulfide bonds 
and two N-linked oligosaccharide chains extending from asparagine (Asn) residues at 
positions 56 and 82.  The TSH-β subunit is a slightly larger peptide chain with 118 
amino acid residues, six intramolecular disulfide bonds, and one N-linked carbohydrate 
chain extending from an Asn residue at position 23 (Yang et al., 2000a,b).  While non-
covalent bonds such as Van Der Waals, hydrogen, ionic and hydrophobic interactions 
are largely responsible for TSH-α and TSH-β dimerization, a "seatbelt" region is formed 
by two disulfide bonds between three cysteine amino acids of the TSH-β subunit which 
wraps around and stabilizes the α subunit (Grossman et al., 1997). 
 Thyroid stimulating hormone is termed an N-linked glycoprotein due to the long 
chains of carbohydrates that are attached to the N-groups of specific asparagine residues, 
two on the α subunit and one on the β subunit.  Glycosylation is the process of 
enzymatically attaching and altering a chain of carbohydrates, such as sugars, onto a  
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protein or other molecule.  These Asn, N-linked oligosaccharides have been shown to 
affect TSH by: increasing plasma half-life, increasing bio- and immuno-activity, 
promoting subunit dimerization, and enhancing biosynthesis and secretion (Szkudlinski 
et al., 1995).  In eukaryotes, N-linked glycosylation is performed in the endoplasmic 
reticulum (ER) and Golgi apparatus as a post translational modification to proteins.  
Oligosaccharides containing 3 fucose, 9 mannose, and 2 N-acetylglucosamine molecules 
are attached to the N-group of an asparagine residue by the enzyme 
oligosaccharyltranferase (Mohorko et al., 2011).  In the Golgi apparatus, fucose and six 
mannose molecules will be enzymatically cleaved by α-glucosidase and α-mannosidase, 
respectively.  This is followed by the enzymatic additions of fucose, mannose, galactose, 
N-acetylglucosamine, N-acetylgalactosamine, and/or sialic acid (N-acetylneuraminic 
acid).  The following table 1 lists the various carbohydrates and the enzymes used for 
removal or attachment to a developing chain: 
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Table 1.  N-linked Glycan Structures.  These are comprised of various carbohydrates 
which are enzymatically added or removed from the developing chain. 
Carbohydrate Removal Enzyme Attaching Enzyme 
N-acetylglucosamine N-acetylglucosaminidase N-acetylglucosaminyltransferase 
Mannose α-mannosidase Mannosyltransfease 
Fucose α-glucosidase Fucosyltransferase 
Galactose α-galactosidase Galactosyltransferase 
N-acetylgalactosamine N-acetylgalactosaminidase N-acetylgalactosyltransferase 
Sialic acid Sialidase Sialyltransferase 
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 The carbohydrate molecules and the order of their addition to the truncated chain 
is species driven.  For example, figure 1 illustrates that insects and mammals have 
similar glycosylation patterns with insect cells producing paucimannose N-glycans and 
mammalian cells producing complex N-glycans.  The paucimannose structure consists of 
2 N-acetylglucosamine and 3 mannose molecules while a complex N-glycan uses the 
same framework as the paucimannose but adds to the structure with any number and 
combination of the previously mentioned carbohydrates (Jarvis, 2003).  This is an 
important concept when designing a baculovirus system to express mammalian proteins.  
The ability to achieve mammalian glycosylation is not inherent to the insect cells so the 
insect cells must be programmed to produce the enzymes necessary for mammalian 
glycosylation.  Also present must be the substrates onto which the enzymes will act in 
order to propagate the carbohydrate chain in the same manner as would a mammalian 
cell. 
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 Figure 1.  Insect and Mammalian Glycosylation Pathways.  A common pathway is shared 
between insect and mammalian glycosylation.  While mammalian cells will regularly produce 
complex carbohydrate chains, insect cells generate a more truncated version of the mammalian 
glycan but demonstrate the ability to form more complex structures (Jarvis, 2003). 
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 Stimulation of TSH production and subsequent release is affected by TRH, 
which consists of three amino acids, binding to the thyrotropin releasing hormone 
receptors (TRH-R) on the thyrotropes of the adenohypophysis.   There exist two 
different forms of TRH-R, TRH-R1 and TRH-R2.  Both forms are found outside the 
anterior pituitary while only the TRH-R1 form inhabits thyrotropes (Neumann et al., 
2010).  As a G protein-coupled receptor (GPCR), TRH-R initiates outside of the cell (N-
terminus) then forms seven transmembrane, α-helix loops and terminates inside the cell 
(C-terminus).  This enables extracellular molecules to cause an intracellular effect by 
binding to the N-terminus promoting a conformational change of the receptor protein 
initiating a cascade of events.   A GPCR will mediate the signal of a bound hormone by 
the cAMP or the diacylglycerol/inositol triphosphate (DAG/IP3) pathway.  Studies have 
shown TRH stimulates TSH secretion by the DAG/IP3 pathway with little support for 
the cAMP cascade (Mariotti, 2011).  Both mechanisms share the same initial steps where 
hormone binding and subsequent receptor conformational change promotes the 
replacement of guanosine diphosphate (GDP) on the inactive α subunit of the G protein 
with guanosine triphosphate (GTP).  This, in turn, leads to the activation of the G protein 
and dissociation of the βγ subunits from the α subunit.  The G protein βγ dimer will 
activate the membrane bound phospholipase enzyme resulting in the breakdown of 
membrane phospholipid phosphatidylinositol 4, 5-bisphosphate (PIP2) into DAG and 
IP3.  The DAG molecule will activate protein kinase C (PKC) leading to TSH gene 
transcription.  IP3 will promote intercellular Ca
2+ 
concentrations to rise via stimulating  
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the smooth endoplasmic reticulum to release its Ca
2+ 
stores and by opening Ca
2+ 
channels in the cell membrane allowing for an efflux of Ca
2+ 
from the extracellular fluid.  
An increase in intercellular Ca
2+
 concentrations stimulate the transcription of the TSH 
gene by activating PKC through direct binding to the enzyme or indirectly by binding 
first to calmodulin which will then activate PKC (Mariotti, 2011).  The intercellular Ca
2+
 
increase also stimulates exocytosis of the secretory vesicles containing the mature TSH 
molecules.
 
 The thyroid stimulating hormone receptor (TSH-R) belongs to the glycoprotein 
hormone receptor (GPHR) family due to the N-linked glycosylation of this hormone 
receptor.  GPHRs are a subset of the larger leucine-rich repeats containing GPCRs 
(LGR) family which are also a subset of the GPCR superfamily (Farid and Skudlinski, 
2004).  As with other GPCRs, TSH-R contains seven transmembrane, α-helix loops with 
an intracellular C-terminus and an extracellular N-terminus. 
  
9 
 
 Figure 2.  Interaction Between Thyroid Stimulating Hormone and Receptor.  The interaction 
between the large extracellular domain of TSH-R (grey) and the TSH molecule (Szkudlinski et 
al., 2002).  The TSH-α subunit is shown in white and the TSH-β subunit is shown in black.  Note 
the "seatbelt" loop formed on the terminal segment (upper left) of the TSH-β subunit. 
“seatbelt” loop 
TSH-α subunit 
TSH-R 
TSH-β subunit 
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 As shown above in figure 2, the TSH-R contains a large extracellular domain 
with nine leucine-rich repeats seen forming an arch around the TSH molecule.  Unlike 
TRH-R, ligand binding to the TSH-R will favor activation of the cAMP cascade to 
propagate the effects of hormone binding rather than the DAG/IP3 mechanism (Metcalfe 
et al., 1998; Dremier et al., 2007).  Similar to the DAG/IP3 pathway, activation through 
ligand binding of TSH-R will promote the substitution of GDP with GTP activating the 
G protein; however, the G protein will activate adenylate cyclase which transforms 
adenosine triphosphate (ATP) to cAMP.  Once converted, cAMP activates protein 
kinases needed to drive the formation of T3 and T4 by the follicular cells of the thyroid 
gland. 
 The canine thyroid is a bi-lobed, secretive gland containing numerous follicles.  
The follicles are spherical in shape formed by a single layer of simple cuboidal epithelial 
cells.  The center of this sphere forms a reservoir where colloid material is stored.  
Colloid represents a mixture of substances (i.e. thyroglobulin, iodine) utilized by the 
follicular cells to manufacture thyroid hormones.  The primary substrates utilized for the 
production of T3 and T4 are: iodide, thyroglobulin, tyrosine, thyroid peroxidase, and 
various lysosomal proteases.  Thyroglobulin, a large glycoprotein produced by the 
thyroid follicular cells, serves as a backbone for multiple tyrosine residue attachments.  
The thyroglobulin/tyrosine structure is packaged into a vesicle by the rough endoplasmic 
reticulum and undergoes exocytosis into the colloid.  Under stimulation by TSH binding, 
the thyroid follicular cell will actively transport iodide from circulation via an energy 
requiring sodium-iodide pump, across the cell, and into the follicular reservoir.  Upon 
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deposition into the colloid, thyroid peroxidase oxidizes the iodide molecules forming 
very reactive intermediates which will rapidly iodinate the tyrosine residues attached to 
the thyroglobulin protein.  Following iodination, the tyrosine residues will couple 
forming T3 or T4 depending on the iodinated state of the individual tyrosine residues.  
Monoiodotyrosine (MIT) is formed when a tyrosine residue carries one iodide while 
diiodotyrosine (DIT) is a fully iodinated tyrosine residue with two iodide molecules.  
Two DIT moieties form T4 and one MIT coupled to one DIT will make T3.  Iodination 
and coupling occurs in close proximity to the colloid-follicular cell border allowing for 
endocytosis of colloid material, including thyroglobulin, back into the follicular cell. 
Lysosomes will fuse with the colloid vesicle where lysosomal enzymes will break down 
thyroglobulin liberating MIT, DIT, T3, and T4.  The T3 and T4 hormones will enter 
circulation while MIT and DIT will be deiodinated and recycled for future thyroid 
hormone production (Greenspan and Baxter, 1994). 
 Once in circulation, T3 and T4 will find protection from circulating enzymes that 
might break down the thyroid molecules by binding to carrier proteins such as albumin, 
thyroxin binding globulin (TBG), or transthyretin (TTR) (Bartalena, 1990).  These 
proteins will also increase the plasma solubility of thyroid hormones while in circulation 
as T3 and T4 are lipid soluble with the ability to pass through plasma and nuclear 
membranes of cells.  The half-life of T4 can range from 5 to 7 days while T3 is only 1 
day.  This could explain why T4 is released from the thyroid in much greater amounts 
than T3 (20 to 1).  Though the majority of thyroid hormones found in circulation are 
attached to binding proteins, small amounts are available in a "free" form.  The "free" 
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hormones are not bound by the constraints of a large a carrier molecule and may pass in 
and out of circulation and cells.  Once inside the cell, deiodination by 5' deiodinase 
converts T4 into T3 which is the ligand for nuclear thyroid receptors (TR).  This 
intracellular conversion implies that T3 is the hormonal effector with the role of T4 
being one of a prohormone.  It must be noted that nuclear TRs are nondiscriminatory as 
to whether T3 originates from circulation or from T4 deiodination.  The T3-TR complex 
will bind to a thyroid hormone responsive element which will alter RNA polymerase II 
activity on a gene responsive to T3 (Greenspan and Baxter, 1994).  Released T3 and 
unmodified T4 will enter circulation again to be metabolized by the liver or serve as 
negative feedback mechanisms at the hypothalamus and anterior pituitary inhibiting 
TRH and TSH secretion, respectively. 
 Many intermediate mechanisms exist separating the recognition of low, systemic 
thyroid hormone concentrations and the replenishing of T3 and T4 by the thyroid gland.  
Defects in these mechanisms could lead to a state of hypothyroidism.  In the canine, 
hypothyroidism is an extremely common endocrine disease that is usually acquired 
rather than congenital.  Primary hypothyroidism, reduced output of thyroid hormones 
directly due to lack of thyroid gland function, is the main cause of the disease.  
Secondary and tertiary hypothyroidism is rare, but documented as defects in pituitary 
and hypothalamic output, respectively (Mooney, 2011).  Euthyroid illness will also 
depress T3 and T4 concentrations even though the thyroid gland is fully functional.  For 
example, Cushing's Disease occurs when the adrenal glands produce an excess of 
cortisol.  An overabundance of serum cortisol can suppress thyroid output; however, 
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thyroid function is likely to return upon resolution of the hyperadrenocorticism 
(Kenefick and Neiger, 2008). 
 With the major proportion of canine hypothyroidism caused by destruction of the 
thyroid gland tissues, two histological causes exist for this form of the disease: 
lymphocytic thyroiditis and idiopathic follicular atrophy (Graham et al., 2007).  
Lymphocytic thyroiditis, an autoimmune disease, occurs as lymphocytes invade the 
thyroid gland effectuating destruction to the thyroid follicles.  This condition can be 
determined through the detection of thyroglobulin autoantibodies (TgAA).  The onset of 
lymphocytic thyroiditis is marked by the presence of TgAA and still normal T3, T4 and 
TSH concentrations.  As the disease slowly progresses, the subclinical phase is 
represented by positive TgAA titers, normal T3 and T4, but TSH starts to rise as thyroid 
tissue is destroyed and the remaining tissue strains to maintain thyroid hormone 
production.  When the clinical phase is reached, TgAA concentrations are still elevated 
and over 75% of thyroid tissue has been destroyed resulting in low plasma T3 and T4 
concentrations causing an increase in TSH production by the thyrotropes of the anterior 
pituitary.  When TgAA concentrations finally recede, little thyroid tissue is left and the 
individual is left in a permanent state of hypothyroidism marked by increased TSH and 
low T3 and T4.  Idiopathic follicular atrophy occurs when thyroid tissue is destroyed and 
replaced by adipose or fibrous, connective tissue.  The exact cause of idiopathic 
follicular atrophy remains unclear; however, the end result mirrors that of lymphocytic 
thyroiditis (Graham, 2009). 
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 Due to the high incidence of hypothyroidism in the canine, definitive diagnostics 
are important to assist the clinician in determining the state of the thyroid gland in his or 
her patients.  Clinical signs of hypothyroidism include, but are not limited to: lethargy, 
weight gain, alopecia, hyperpigmentation, seizures, cold intolerance, and reproductive 
issues such as peri-parturient mortality in pups (Panciera et al., 2007).  Fortunately, 
diagnostic labs offer many thyroid hormone assays such as T3, reverse T3, Free T3, T4, 
Free T4, Free T4 by dialysis, and TgAA.  Unfortunately, the laboratory results 
sometimes do not reflect the clinical findings of hypothyroidism due to interactions by 
thyroid-like molecules (i.e. TgAA) interacting with the assays giving a false-negative 
diagnosis.  Non-thyroidal illness or thyroid inhibiting drugs (i.e. propylthiouracil (PTU) 
(Richards and Ingbar, 1959)) could depress thyroid function providing a false-positive 
diagnosis of hypothyroidism on an otherwise healthy thyroid gland.  In the past, to 
combat the possibility of a false diagnosis, the TSH response test was employed and 
considered the “Gold Standard” for diagnosing primary hypothyroidism.  The protocol 
for administering this test included drawing a baseline blood sample, injecting 0.2 iu/kg 
of bTSH intravenously (IV), and drawing a 6 hour post blood sample (Panciera, 1999).  
Both blood samples would then be assayed for T4 concentrations to determine if the 
thyroidal output was an appropriate response to what was considered normal for the 
bTSH injection.  Concerns arose as some patients reacted adversely (anaphylaxis) to the 
chemical grade bTSH as a pharmaceutical grade bTSH was not available (Panciera, 
1999).  An additional consideration when using bTSH is the injection of a hormone 
produced by the neural tissue of a one species into another.  This could introduce 
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diseases such as rabies or bovine spongiform encephalopathy into a companion animal.  
Since bTSH is not approved for use by the U.S. Food and Drug Administration (FDA), 
its use as a diagnostic tool is not appropriate. 
 To circumvent the need to harvest and purify tissue samples from individuals in 
order to isolate a specific protein to use as a source of an exogenous hormone, various 
methods have been employed to manipulate a "host" cell to produce a recombinant 
version of that specific protein.  The relative ease of designing and assembling a strand 
of deoxyribonucleic acid (DNA) and utilizing natural, cellular processes provide the 
tools for the reprogramming of cells to perform a given task.  The DNA encoding the 
recombinant protein must be inserted into the host cell where the transcribing and 
translating mechanisms of the host cell are appropriated in order to produce the mRNA 
and the assembled protein, respectively.  The insertion is achieved by means inherent to 
the host cell.  For example, if using bacteria such as Escherichia coli (E-coli) as an 
expression vector, a compatible plasmid is opened to receive the recombinant protein 
DNA.  The plasmid vector is then transformed into the E-coli cells where the 
recombinant protein gene will be inserted into the host cell DNA and transcribed along 
with the other genes on the plasmid vector (Baneyx, 1999).   
 Selection of the host cell is dependent on the size, complexity (i.e. multiple 
chains, folding, glycosylation, disulfide bonds, phosphorylation), amount of expression, 
and function of the protein.  Selection of the transfer vector will be determined by its 
ability to infect the host cell.  Choices of protein expression systems include: chemical 
synthesis, cell-free, yeast, bacterial, plants, insect cells, and mammalian cells.  
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Production time and fiscal constraints may also factor into the choice of a protein 
expression system.   
 Since the early 1980s, baculovirus systems have been used to express 
recombinant proteins.  Researchers hoped this system would produce proteins in high 
quantities similar to bacterial expression systems while performing typical mammalian 
modifications such as phosphorylation and glycosylation (Jarvis, 2009).  The hypothesis 
that a baculovirus would provide high concentrations of protein expression was based 
upon the protein, polyhedrin.  As a baculovirus propagates, it produces two types of 
virion: a cell to cell type that buds from the infected cell to attack another cell in the host 
and an occlusion type that is protected within a protein matrix (polyhedrin) and can 
survive the death of the host (van Oers, 2011).  After ingestion by another insect, the 
protective polyhedrin capsule and matrix will be digested allowing the hibernating virus 
to infect the cells of the gut lining.  Fortunately, utilizing a baculovirus and insect cells 
to express mammalian proteins dispels the concerns of using a virus during the 
proteogenic process as a baculovirus' effects are limited to insect hosts.  If the gene 
sequence for polyhedrin is replaced by a gene of interest (GOI), then the same promoters 
used to produce large amounts of polyhedrin may be employed to produce similar 
quantities of recombinant protein encoded by the GOI. 
 Initially, scientists utilized the Autographa californica nuclear polyhedrosis virus 
(AcNPV) to infect cells from the Lepidoptera order, or more specifically the Spodoptera 
frugiperda (fall armyworm, Spf), with the GOI which coded for human beta interferon 
(hIFN-β).  The Spf was chosen due to its cells' ability to produce and store polyhedrin to 
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amounts where 25% or more of the total protein mass in the infected cell is the 
polyhedrin protein (Smith et al., 1983).  At the time, extensive research had been 
performed on AcNPV which made the virus an excellent candidate for recombinant 
protein expression by a baculovirus/insect cell system.  It was determined that AcNPV 
could infect cells of various tissues in a broad range of insects in the Lepidoptera order 
while most other baculoviruses are much more limited in their selection of hosts (Jarvis, 
2009).  The DNA of the AcNPV also contained the gene encoding for the polyhedrin 
protein which could be removed at no detriment to the normal functions of the AcNPV 
(Smith et al., 1983).  This introduced the possibility of replacing the polyhedrin gene 
with a GOI and not interfering with transcription of the modified viral DNA into 
messenger ribonucleic acid (mRNA) since removing the polyhedrin gene produced no ill 
effects. 
 In order to insert the GOI into the baculovirus DNA, naturally occurring 
mechanisms such as bacterial transformation and homologous recombination were 
utilized.  A bacterial plasmid, pUC8, was inserted with the gene encoding human 
interferon β (hIFN-β) into its circular DNA strand along with 5' and 3' flanking regions 
that are identical to the same regions that flank the polyhedrin gene of the AcNPV.  Also 
encoded on this plasmid is the resistance to ampicillin which will be important when 
determining which bacteria took up the designer plasmid.  Bacteria undergo 
transformation which is the uptake of DNA, such as plasmids, from the environment.  
By introducing the designer plasmid to compatible bacterial cells, in this case E-coli, 
transformation is allowed to occur.  The cells are then placed on a culture plate which 
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contains ampicillin in the medium.  The plated bacteria experiencing colony growth 
must contain the gene for ampicillin resistance which was included on the designer 
plasmid.  The surviving colonies are used to produce stocks of the designer plasmid 
(Baneyx, 1999). 
 Once an ample supply of the designer plasmid was available and purified, 
cotransfection with DNA from the AcNPV was performed on cells from Spf.  Though 
the occurrence was minute, the viral and plasmid DNA exchanged genes via 
homologous recombination before infecting the cell.  The cells which contained the 
chimeric viral DNA would produce hIFN-β instead of the polyhedrin protein.  The 
infected cells were plated on growth medium and the colonies which produced 
polyhedrin containing occlusion bodies did not recombine with the plasmids while 
colonies lacking occlusion bodies measured positive for hIFN-β production (Smith et al., 
1983).  This was the first introduction to manipulating insect cells into producing 
mammalian proteins.  While hIFN-β is comprised of a single chain (187 amino acids) 
with N-linked glycosylation occurring at amino acid residue 101 
(www.uniprot.org/uniprot/P01574), cTSH is a much more complex glycoprotein 
hormone bicistronically transcribed with multiple post-translational glycosylation sites.  
Fortunately, advancements in the field of baculovirus technology will provide for the 
additional demands placed on insect cells to produce complex, multi-chain, mammalian 
proteins. 
 Utilization of cell culture bioreactors allows for the mass expression of the GOI 
inserted by baculovirus infection into host cells in order to produce large quantities of 
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the designer protein.  Culture media, pH, temperature, and dissolved oxygen may be 
monitored and manipulated via control mechanisms available on the bioreactor.  Greater 
control of the variables results in greater costs of the equipment.  Fortunately, various 
models are available to accommodate for the amount of investment a company or 
individual is willing to apply towards protein expression.   
 Upon completion of the cell culture, the protein of interest (POI) must be isolated 
from byproducts of the expression process such as cellular debris and unwanted proteins 
also produced by the cultured cells.  Purity is especially important for sensitive analysis 
of the protein (i.e. mass spectrometry) or if the protein will be used as a pharmaceutical 
agent.  One technique made available in the 1940’s, which won Moore and Stein the 
Nobel Prize, and used widely in protein purification is ion exchange chromatography 
(IEX) (Ward and Swiatek, 2009).  Ion exchange resins are available which consists of 
chemical functional groups that are attached to very small, insoluble beads (i.e. 3-90 
µm).  These beads are poured and packed tightly into a column.  This is known as the 
stationary phase.  Various functional groups are available which will act differently 
either attracting anions (basic functional groups) or cations (acidic functional groups).  
These are divided into two further subsets: groups remaining charged regardless of 
environmental pH (strong ion exchangers) or groups whose charge may be altered 
depending on environmental pH (weak ion exchangers). Strongly acidic, strongly basic, 
weakly acidic, and weakly basic functional groups are typically composed of sulfonic 
acid, quaternary amino, carboxylic acid, and primary, secondary, or tertiary amino 
groups, respectively.  In using ion exchange chromatography, the isoelectric point (pI) of 
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the protein will dictate the overall charge of the protein dependent on the pH of the 
environment.  If the pH of the environment is less than the pI of the protein, then the 
protein will be positively charged.  Conversely, if the pH of the environment is greater 
than that of the protein’s pI, a negative charge will be carried by the protein (Zhu et al., 
2005).  The power of ion exchange chromatography utilizes this ability to manipulate the 
charge of the proteins and enhance separation.  Once a strategy has been formed, the 
media containing the POI is prepared to the proper pH.  The media is known as the 
mobile phase.  The media will flow through the ion exchange resin allowing molecules 
in the mobile phase to interact with the functional groups of the stationary phase.  The 
flexibility of ion exchange allows the user to capture either the POI or the unwanted 
material to the resin. Any adsorbed molecules may be desorbed from the stationary 
phase by introducing competing ions (i.e. sodium chloride (NaCl)) that will replace them 
and effectively block the charges of the functional groups on the stationary phase.  The 
greater the charge of the captured molecules, the greater the concentration of competing 
ions needed to dislodge the material.  For this reason, a gradient elution is used to 
enhance the degree of separation between molecules of varying ionic strength and thus 
leading to increasing purity, in theory.  Glycoproteins can have various pI’s which can 
be primarily explained by the variations in the oligosaccharide chains due to the 
presence or absence of sialyl and/or sulfate groups (Chiba et al., 1997).  Charge 
heterogeneity has been attributed to the multiple glycosylation patterns which translate 
into multiple pI values for bovine, ovine, and human TSH (Green and Baenziger, 
1988a,b).  Understanding the effect glycosylation has on the pI of glycoproteins will 
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help to define the parameters for ion exchange chromatography which will be used for 
the purification of rcTSH. 
 An end result of ion exchange chromatography is a collection of eluent 
containing the POI in a solution of salt.  The next step in the purification process is to 
concentrate the POI and remove salt.  This may be achieved with tangential flow 
filtration (TFF) (Ward and Swiatek, 2009).  As demonstrated in figure 3, a filter with 
pores of a specific diameter is utilized to separate molecules of sizes above and below 
the pore diameter.  Driving pressure to push the starting material parallel the TFF 
membrane is generated by a pump.  As material flows tangential to the membrane, part 
of the driving pressure is translated into force perpendicular to the membrane.  The 
perpendicular force will push material towards the membrane carrying water and any 
molecules smaller than the pore diameter over into the filtrate.  The advantage of 
applying driving force parallel to the filter is reducing the amount of material adhering to 
the membrane leaving pores open and maintaining filtration efficacy.  Filtration systems 
that apply force perpendicular to the filter create a buildup of material too large to flow 
through the pores.  This will restrict flow by blocking the pores, increasing back 
pressure, and greatly reducing filtration efficiency. 
  
22 
 
 Figure 3.  Tangential Flow Filtration.  In TFF, pressure is applied to the retentate by a pump.  
The driving pressure created by the pump is predominately distributed between forces parallel 
and perpendicular to the TFF membrane. 
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 In order to visualize the effectiveness of a purification process, gel 
electrophoresis and western blot analysis can demonstrate the purity of a sample as well 
as show that the detected protein is the POI.  The fundamentals of gel electrophoresis 
date back to 1791 when Faraday introduced his laws of electrolysis.  Researchers such as 
Kohlrauch and Tiselius expanded upon Faraday's laws of particle size and movement 
through an electric field and developed moving boundary electrophoresis which is a 
defined front or line of particles migrating through a medium pushed by an electrical 
current (Vesterberg, 1993).  By acting as a sieve, the medium could separate individual 
components of the sample based on the sizes of the molecules.  Shapiro et al. (1967) 
published their success in estimating the molecular weight of various polypeptides by 
SDS-PAGE.  Sodium dodecyl sulfate is an anionic detergent which will denature 
proteins by binding to the polypeptide backbone unfolding the protein into a long, strait 
structure.  Sodium dodecyl sulfate will also bind to proteins at a constant rate of 1.4g 
SDS to 1 g of protein (Daban et al., 1991).  This will ensure the amount of anionic 
charge provided by the SDS will be proportional to the mass of the protein and that the 
intrinsic charges of the proteins are voided by the SDS and will not affect protein 
migration towards the anode (Shapiro et al., 1967).  When a sample containing unknown 
amounts of various proteins is treated with SDS and applied to an electrophoresis gel, 
separation will occur due to the true size of the unfolded proteins. 
 Various substances have been used as gel electrophoresis mediums such as free 
solution, paper, gelatin, agar, and polyacrylamide.  Raymond and Weintraub (1959) 
performed zone electrophoresis using acrylamide gels and published their findings 
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(Vesterberg, 1993).  Acrylamide gels are formed by the cross-linking of long, 
acrylamide chains by a polymer such as bisacrylamide.  The pore sizes produced by the 
acrylamide/bisacrylamide cross-linking may be manipulated allowing for various sieving 
properties depending on the gel formulation (i.e. greater bisacrylamide content yields 
smaller pore sizes).  Raymond and Weintraub (1959) found that acrylamide gels 
presented multiple characteristics beneficial to electrophoresis such as: 
 Once the gel is formed, it is colorless, clear, elastic, water insoluble, and stable. 
 After electrophoresis, the gel can be dried and then stored.  The stored gel could 
later be rehydrated by soaking in water which will return the gel to its 
approximate original size before shrinking during the drying process. 
 Staining of the gel produced sharper bands (less sample diffusion) as well as 
reduced background staining. 
The visualization of the proteins applied to the gel as distinct bands with excellent 
contrast to reduced background staining was greater than any other medium available 
during the time of this experiment (Raymond and Weintraub, 1959).  Pre-casted 
polyacrylamide gels are presently available in different configurations (gel size, well 
size, sieving properties) by various manufacturers but can still be mixed, poured, and 
casted by hand. 
 Once SDS treated proteins have undergone electrophoresis on a polyacrylamide 
gel, stains are applied to the gel.  The amount of sample proteins on the gel, the affect 
the stain will have on the sample proteins if further research is needed (i.e. mass 
spectrometry), and the specificity of the stain to a POI are factors to be considered.  
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Coomassie brilliant blue (CBB), silver, and fluorescent staining are all available for 
protein visualization each having its advantages and disadvantages.  Coomassie brilliant 
blue was originally developed as a textile dye and was later adopted by researchers as a 
detection tool for proteins.  This anionic dye when in acidic solution will reversibly, 
non-specifically bind to the exposed ammonia (NH3 
+
) groups of proteins (Fazekas de St. 
Groth et al., 1962).  The detection limit of CBB R-250 towards microgram amounts of 
protein ranges from 0.3 - 1 µg/band which is the least sensitive of the three; however, 
costs are lower and working time is shorter (Sasse and Gallagher, 2009).  Alternative 
protocols are being developed to decrease the needed amount of protein to produce a 
visual band while maintaining the ability to further analyze the in-gel proteins after 
exposure to CBB (Pink et al., 2010).  Silver staining has much greater sensitivity at the 2 
- 5 ng/band amounts but requires a longer and more detailed protocol (Sasse and 
Gallagher, 2009).  Researchers introduced silver staining of polyacrylamide gels to 
detect proteins and peptides in 1979 and the fundamentals of their silver staining 
protocol are still in use (Switzer et al., 1979).  After gel electrophoresis, the proteins are 
fixed to the gel and then sensitized to the subsequent addition of silver ions.  Image 
development is performed on the gel to expose the protein bands.  Fixation, 
sensitization, silver attachment, and visualization all occur using various chemicals.  One 
of the chemicals used to increase the sensitivity of the silver stain to small, nanogram 
amounts of protein is formaldehyde.  Unfortunately, post staining analysis such as mass 
spectrometry of the proteins after exposure to formaldehyde is difficult as modifications 
to proteins are induced by the chemical.  Formaldehyde may induce cross-linking and 
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the attachment of methylol and imidazolidione adducts to amino/thiol and N-terminal 
groups, respectively.  These changes can alter the sizes of the peptides which construct 
the total protein as well as hinder cleavage points normally accessible by enzymatic 
digestion (Metz et al., 2006). 
 A third type of stain which combines the advantages of Coomassie blue and 
silver staining is fluorescence.  An example of a fluorescent dye, SYPRO Ruby, is an 
organic compound with ruthenium chelated to the complex (Berggren et al., 2000).  
Ruthenium, a luminescent metal, is highly excited when exposed to UV light or a laser. 
When an electrophoresis gel is exposed to SYPRO Ruby, the molecules of the dye will 
bind electrostatically to the basic amino acid residues (i.e. lysine, arginine, histidine) of 
the sample proteins in a similar manner as CBB.  Detection without the use of 
visualization equipment is possible by ultraviolet (UV) light; however, fluorescence of 
the stained proteins are fully realized with the use of a laser scanner or charged-coupled 
device (CCD) camera (Patton, 2000).  Exciting the protein-bound ruthenium complexes 
with an energy source coupled with precise detection equipment will produce 
sensitivities equaling that of silver staining while leaving further downstream analysis of 
the proteins available due to the binding mechanism shared with CBB. 
 Non-discerning dyes present the total protein content applied to an 
electrophoresis gel creating an image of the variances in molecular weights and/or 
isoelectric points of the sample proteins.  In order to determine the location of the POI 
on the gel, a much more precise method must be employed.  The heightened specificity 
of western blot analysis of a polyacrylamide gel utilizes antibodies developed towards 
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the POI.  After electrophoresis, the proteins embedded in the gel are transferred 
electrophoretically to a protein adsorbent material such as nitrocellulose or 
polyvinylidene flouride (PVDF) resulting in the sample proteins maintaining the same 
relative locations on the transfer membrane as on the gel.  Since nitrocellulose and 
PVDF bind proteins indiscriminately, a blocking agent is applied to the membrane to 
cover any open binding sites that the antibodies added in the following steps might 
inhabit.  The primary antibody specific to the POI is introduced to the membrane.  A 
secondary antibody produced towards the animal species the primary antibody was 
developed in is tagged with a probe (i.e. radioactive, chemiluminescent, and 
colorimetric) and exposed to the membrane.  Depending on the probe, visualization 
techniques will develop an image of the locations where the secondary antibody has 
bound the primary antibody-POI complex on the membrane (Towbin et al., 1979). 
 If the purified POI is to be used as a pharmaceutical agent, efficacy trials will 
determine the protein's ability to elicit a biological response.  In vivo and in vitro 
systems/protocols are numerous providing many options to the researcher.  A few factors 
in determining which system to use include: accessible equipment, finances, type of cell 
that expresses receptor to POI, reagents for measuring biological endpoint, time 
constraints, and the technical skill to design and perform the experiment.  
  In vitro studies can provide an estimate to the in vivo activity of the POI.  The 
success of an in vitro system depends on the ability to emulate an in vivo environment by 
providing the necessary nutrients to the cultured cells or tissues promoting growth, 
maintenance, and the ability to respond to stimulatory or inhibitory actions of a ligand.  
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The number of nutritional delivery variables one wishes to manage during a culture will 
dictate the complexity of the system.   
 The supply of nutrients to the tissue or cell culture is either statically or 
dynamically controlled.  In static cultures, media composed of varying substances at 
specific concentrations is added to the biological sample contained in a vessel (i.e. Petri 
dish, test tube, flask).  The concentration of the substances will decrease in the media as 
the biological sample utilizes them in accordance to the Michaelis-Menten kinetics of 
enzyme reaction on a substrate (Sugiura and Kanamori, 2011).  While less intricate and 
costly than dynamic culture systems, availability of sustenance slowly decreases in static 
cultures which might reduce the effectiveness of the biological sample during 
treatments.  Carrel and Burrows (1911) performed possibly the first documented static 
cultures on thyroid tissue fragments (Pulvertaft et al., 1959).  The primary culture 
consisted of the thyroid tissue sample placed in the plasma medium of the same animal 
donor.  Secondary and tertiary cultures were also performed where cells from the 
previous culture were taken and cultivated in new plasma medium.  The nutritional 
concerns for cell maintenance during static culture are observed in their writings: 
 
 "The death of the culture is bound up with the changes induced in the  
 plasma by the growing cells. This is shown by the fact that on secondary 
 transplantation the cells continue to multiply.  It may be caused by  
 exhaustion of the nutriment or by accumulation of metabolic products or  
 by both of these factors together." (Carrel and Burrows, 1911). 
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 In contrast to static cultures, a dynamic system maintains a constant 
concentration of nutrients in the vessel containing the biological sample.  This is 
achieved by pumping media to the culture vessel at the same rate as the biological 
sample is consuming the media components.  Dynamic cultures such as perifusion 
systems greater emulate in vivo performance than static promoting biological sample 
longevity and reactiveness to a ligand (Hassan and Merkel, 1994).  In 1980, perifusion 
experiments were first conducted utilizing mammalian thyroid tissue to determine the 
response of rat thyroid cells to TSH delivered in a dynamic system (Attali et al., 1984; 
Grau et al., 1986).  A basic perifusion system consists of culture chambers designed for 
housing tissue samples with afferent tubing delivering fresh media to the chamber from a 
reservoir via a peristaltic pump and efferent tubing delivering the media with the 
products released by the sample tissue to a collection device.  Because the tissue sample 
will be stationary in the vessel, the importance of vessel shape and size is important so as 
to allow for maximum contact by all cells of the culture to the mobile media.  Care must 
be taken to not overload the chambers with tissue which might restrict media flow as 
well as reduce the surface area of the biological sample exposed to the media as fluids 
tend to take the path of least resistance and will follow the same route.  Another 
consideration when using a perifusion system is the fluid flow through the tubing and the 
chamber, both of which resemble pipes.  Changes in pipe radius and length, temperature, 
and fluid velocity combined with Taylor dispersion will create diffusive effects altering 
hormone profiles (Shorten and Wall, 2001).  While these alterations might be too minute 
for the average perifusion experiment, using alike culture chambers as well as tubing 
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material, radius, and length will aid in ensuring diffusive properties are similar across 
experimental groups (Grau et al., 1986). 
 Forskolin, a potent activator of adenylate cyclase, initiates a cascade resulting in 
the production of cAMP which in the thyroid gland ultimately effectuates T3 and T4 
release (Laurberg, 1976).   The actions of forskolin are a useful tool to demonstrate the 
viability of cells or tissue samples after the experimental treatments are applied.  If 
cell/tissue death occurs during the experiment, products such as hormones will be 
released possibly emulating a stimulatory response to a releasing ligand.  A viable 
sample should demonstrate this response to the releasing hormone as well as forskolin if 
the stimulatory cascade utilizes cAMP as a second messenger. 
 The measurements of serum hormones allows researchers to closely monitor the 
amount of the POI used during an experiment as well as determine its effectiveness 
through the measurement of the hormone whose release is stimulated by the POI.  Very 
early bioassays could only detect the presence of a hormone.  For example, serum or 
urine from a human female would be subcutaneously injected into a male Bufo toad.  If 
the toad produced spermatozoa which could be detected in the urine within 3 hours, a 
positive pregnancy would be diagnosed due to the elevated presence of human chorionic 
gonadotropin in the human female's serum or urine causing spermatozoa production in 
the toad (Mainini, 1947).  A different methodology was needed to quantify hormone 
concentrations.  In 1960, the first immunoassay was developed to detect human serum 
insulin concentrations (Goldsmith, 1975).  Researchers discovered hormones labeled 
with a radioactive element (i.e. I
125
) would compete with the non-labeled hormone for 
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specific antibody binding.  If the concentration of I
125 
bound hormone added to a sample 
was kept constant, the amount of non-labeled hormone in the sample would dictate how 
much bound hormone would undergo antibody binding.  The amount of radioactive 
material measured in each sample would be inversely proportional to the amount of non-
labeled hormone present.  A set of standards with known concentrations of hormone is 
used to calculate a standard curve to which samples of unknown hormone concentrations 
may be measured (Yalow and Berson, 1960).  Using the same principles as 
radioimmunoassay, chemiluminescent technology also utilizes competitive binding; 
however, hormones conjugated with radioactive isotopes are instead labelled with a 
substance such as alkaline phosphatase which in the presence of the substrate 3-(2'-
spiroadamantane)-4-methoxy-4-(3'-phosphoryloxy) phenyl-1, 2-dioxetane disodium salt 
(AMPPD) will produce an unstable intermediate that emits light.  The light is measured 
via a photomultiplier tube (PMT) to produce a result (Reimers et al., 1996).   
 A non-competitive binding, or sandwich, assay also may be used in place of 
competitive binding.  Instead of two forms of the same hormone competing for 
antibodies to bind, the sample hormone in a sandwich assay freely binds to stationary 
antibody sites.  Labelled antibody is introduced to the sample tube which binds to the 
captured hormone which is now effectively "sandwiched" between two antibodies.  
Sandwich assays are considered to produce greater sensitivities due to the increased 
specificity of using two antibodies while competitive binding, only utilizing one 
antibody, will be more prone to non-specific binding by hormone fragments (Prudom et 
al., 2010).  Radioactivity is measured or substrate is added to illuminate the stationary 
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sample hormone and measured by a PMT, depending on the assay type. Unlike 
competitive binding assays, the result from a non-competitive assay will be 
proportionate to the unknown sample concentration. 
 Statistical analysis of the data will provide the final validation as to whether or 
not the null hypothesis of the experiment is rejected.  Experimental groups are formed 
where a number of individuals are assigned to a particular group and administered either 
a treatment or a control dose.  As the number of groups increase, so does the complexity 
of the statistical analysis when comparing more than two populations.  Analysis of 
variance (ANOVA) is a method of comparing a population parameter across multiple 
groups to test if the null hypothesis, that all groups share the same population value, 
should be rejected.  Analysis of variance provides for this by incorporating the F-test 
which accounts for variance within the experimental groups as well as between the 
experimental groups.  This differs greatly from a t-test which compares just one 
population directly to another.  Once the F-test value is calculated, the corresponding p-
value is determined.  If the calculated p-value is less than 0.05, the null hypothesis is 
rejected (Ott and Longnecker, 2001). 
Should the null hypothesis be rejected indicating a significant difference between 
the group means, the Tukey’s W Procedure may be employed to determine which means 
are different.  Tukey’s W Procedure is very similar to the t-test but uses the studentized 
range distribution instead of the t distribution.  If the t-test were used to compare two 
sample means from a pool of multiple means, the probability is high that eventually a 
type I error will occur even if all the sample means are not significantly different unless 
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the error rate is set to a very small α.  Tukey’s W Procedure compares the difference 
between two of the sample means to the W test statistic calculated using the total number 
of sample means, degrees of freedom (ANOVA), error rate, number of observations per 
group, and the mean square within samples (ANOVA) to aid in avoiding the type I error.  
It is also the preferred comparison of multiple means from sample sizes that are the same 
or slightly varied (Ott and Longnecker, 2001). 
The objective of this research is to determine if rcTSH is comparable to the 
“Gold Standard”, bTSH, which has been discontinued for use in the TSH stimulation test 
used to determine thyroid status in canines.  Necessity for FDA approval as an injectable 
pharmaceutical requires rigid purification techniques so as not to introduce a possible 
source of an anaphylactic response by the patient.  As the purification techniques are 
refined, in vitro experimentation will be performed to evaluate the stimulatory effects of 
rcTSH and bTSH on cAMP production in cell culture and T4 release in static and 
perifusion tissue culture.  Upon refinement of the purification technique, bioassays 
including goldfish, rats, and canines will reveal if rcTSH elicits a similar response by the 
thyroid gland as bTSH when used according to the TSH stimulation test protocol. 
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CHAPTER II 
IN VITRO TRIALS 
 
???????? 
 
The efficacy of rcTSH on canine and bovine thyroid tissue was tested utilizing 
primary cell, static tissue, and perifusion tissue cultures.  While purification techniques 
were examined in order to produce a substance suitable for injection, culture systems 
provided estimations as to the physiologic responses of in vivo testing.  In vitro testing is 
performed to determine if the biological actions of rcTSH emulate those of bTSH, the 
“Gold Standard” for determining the canine thyroidal output in response to an injection 
of an exogenous thyrotropic substance.   
The initial experiment, primary cell culture, was performed on canine thyroid 
tissue.  Thyroid cells were liberated and subsequently cultured in preparations for 
exposure to either positive (forskolin) control, negative (media) control, bTSH (1600 ng, 
8000 ng, and 16000 ng doses), or rcTSH (1600 ng, 8000 ng, and 16000 ng doses).  
Equivalent immunoreactive TSH concentrations were made for doses of bTSH and 
rcTSH.  Following treatments and incubation, the media was assayed for cAMP, a 
second messenger in the signaling pathway for the cTSH receptor. 
 The results demonstrated no logical cAMP expression in accordance with the 
treatment type and concentration.  All treatment means were similar to the negative 
control (P>0.05) (mean=0.10025) except the positive control (P<0.05) (mean=0.08100) 
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and the medium bTSH (P<0.05) (mean=0.08750) doses which expressed lower cAMP 
concentrations.  In fact, all treatment means were lower than the negative control except 
for the low rcTSH treatment. 
 The next experiment, static tissue culture, allowed for the measurement of a true 
biological endpoint to TSH actions which is the expression of T4 by thyroid tissue.  
With the inconclusive results of the cAMP experiment, concentrating on the efficacy of 
the recombinant hormone was of primary importance.  Bovine thyroid tissue was 
exposed to media (control) and the same concentrations of rcTSH as used in the cAMP 
experiment while incubating in a warm water bath (37°C).  Media was periodically 
harvested and replenished and assayed for T4 concentrations. 
 Similar results were obtained in the static culture as in the cAMP experiment 
where treatments were similar (P>0.05) to the control at almost all data points.  A 
gradual decrease in T4 release was seen in all treatment groups with no response to 
either rcTSH or forskolin.  This could be an indication that the tissue samples were not 
being maintained by the culture media and/or the environmental conditions in the water 
bath resulted in tissue death. 
 The final in vitro experiment utilized a perifusion culture machine (Endotronics, 
Inc., Coon Rapids, MN) to provide better environmental controls as well as provide a 
constant supply of fresh media to the culture chambers housing the thyroid tissue.  Due 
to a limited number of perifusion chambers available, groups were assigned for media 
(control), bTSH (16,000 ng), and rcTSH (16,000 ng).  A fractionator was used to collect 
media at specific intervals during the course of the experiment and all were measured for 
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T4 concentrations.  While the small number of data points negated the ability to provide 
a meaningful statistical analysis, graphical representation demonstrated the heightened 
thyroidal response of rcTSH and bTSH over the control. 
 
INTRODUCTION 
 
 For the last 30 years, baculovirus mediated recombinant protein expression has 
provided an alternative to producing proteins which emulate their endogenous 
homologues in immuno- and bio-activity (Jarvis, 2009). With the ability to accept codon 
optimized RNA encoding for the protein of interest (POI) in addition to performing 
mammalian glycosylation, baculovirus systems are ideal candidates to manufacture a 
foreign glycoprotein in greater concentrations than their mammalian counterparts and 
have the enhanced ability for complex glycosylation unlike bacterial culture systems.  
This technology offers a tantalizing future for the production of proteins for use in both 
the veterinary and human pharmaceutical industry. 
 Hypothyroidism, an endocrinopathy in the canine, represents a common yet often 
misdiagnosed disease to the veterinarian (Graham, 2009).  Clinical signs along with a 
battery of serological tests (i.e. T3, T4, Free T4, TSH, TGAA) provides insight to the 
functional status of the thyroid gland; however, not all the necessary information to 
make a firm diagnosis may be provided.  To abate this concern, a TSH stimulation test 
would quantify the patient's thyroidal response to an injection of exogenous TSH.  Once 
considered the standard protocol for diagnosing canine hypothyroidism, the TSH 
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stimulation test was performed using bTSH.  A comparison between serum T4 
concentrations before and 4-6 hours after the bTSH injection would reveal if the thyroid 
gland reacted appropriately to the bolus of bTSH (Panciera, 1999).  With bTSH no 
longer approved as a veterinary pharmaceutical and the elevated expense of recombinant 
human TSH (rhTSH) extra-label use, veterinarians are forced to base decisions on 
"snapshots" of thyroid function by submitting serum from random blood draws for 
thyroid hormone assays. 
 To produce rcTSH, cells from Spf of the order Lepidoptera are infected by a 
baculovirus containing recombinant DNA (Jaques and Jarvis, 2010).  Wild-type 
baculovirus infection will force the insect cells to produce the protein, polyhedrin, in 
large quantities.  Substitution of the DNA encoding for polyhedrin with the codon 
optimized sequence for both α and β chains of cTSH located on a designer plasmid 
occurs via homologous recombination.  Insect cells successfully infected will lack the 
visibile presence of the polyhedrin protein and are subsequently cultured for rcTSH 
expression (Jarvis, 2009). 
 After culture, purification techniques are applied to the media in order to isolate 
the rcTSH from unwanted molecules.  In vitro experimentation provided a source of 
information as to the potency of the recombinant stimulatory hormone as the purification 
methodology was refined in preparation for in vivo injection.  The objective to 
performing in vitro experiments was to evaluate the efficacy of rcTSH and compare the 
stimulatory effects to bTSH.  Comparisons will be made by: measuring the ability to 
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stimulate an increase in cAMP concentrations in cultured thyroid cells and measuring T4 
release by thyroid tissue samples in static and perifusion culture systems. 
 
MATERIALS AND METHODS 
 
Expression of rcTSH 
United States patents US 7,479,549 B2 and US 7,838,492 B2 protects the 
methods of production and use of rcTSH as proposed by inventors Dr. John (Scott) T. 
Jaques and Dr. Donald L. Jarvis.  The patents detail the alterations made in the codon 
sequences of amino acids, used to maximize production of rcTSH α and β chains by 
lepidopteran cells.  Also discussed in the patents are the various cell lines infected by the 
baculovirus, AcP(+)DIEcTSHA/B, each of which providing individual, post-
translational glycosylation modifications (Jaques and Jarvis, 2009; Jaques and Jarvis, 
2010). 
To summarize, plasmids containing rcTSH DNA undergoes homologous 
recombination with the baculovirus effectively exchanging the polyhedron encoded 
region for the α and β chains of rcTSH DNA.  The baculovirus infects the lepidopteran 
cells instructing cellular mechanisms to produce rcTSH, not polyhedron.  The infected 
cells are cultured with fresh medium for 5 days.  Centrifugation removes the cells from 
the culture media containing rcTSH.  Expression of rcTSH was provided by Expression 
Systems, Woodland, CA. 
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Purification of rcTSH 
Frozen (-80°C) media containing rcTSH remained refrigerated at 3° C during 
thaw.  Once thawed, the pH of the media was elevated to 9.5 using sodium hydroxide 
(NaOH).  The media was centrifuged at 3000 revolutions per minute (rpm) for 15 
minutes to concentrate particulate matter at the bottom of the container. Media was 
poured through a glass wool filter to capture sediment formed during centrifugation.  
Subsequently, the supernate was then applied to a strong anion exchange column (AEX) 
(Column-Kontes Chromaflex 420830-3020, Resin-GE Healthcare HiTrap Capto Q).  
The cationic charge of the stationary phase attracts molecules with negative charges in a 
9.5 pH environment (Zhu et al., 2005).  With an approximate pI of 8.5 (work performed 
by Dr. Evan Shave of Dr. Gyula Vigh’s lab, Chemistry Department, Texas A&M 
University), most rcTSH does not bind to the column.  The column is washed with three 
column volumes of running buffer to collect unbound rcTSH suspended in the mobile 
phase on the AEX column. 
 Once the harvested flow through media is collected, the pH is adjusted to 5.0 
with acetic acid.  The adjusted media is then applied to a strong cation exchange column 
(CEX) (Column-Kontes Chromaflex 420830-3020, Resin-GE Healthcare HiTrap Capto 
S).  The rcTSH will retain a positive charge and adsorb onto the negatively charged 
groups on the cation resin (Zhu et al., 2005).  Three column volumes of buffer remove 
material suspended in the mobile phase of the CEX column.  To desorb the rcTSH from 
the CEX functional groups, a 1 M NaCl solution is applied to the CEX to allow the salt 
  
40 
molecules to replace the rcTSH on the stationary media and the rcTSH is collected in the 
flow through mobile phase. 
 The final step in the purification process is to remove the NaCl from the CEX 
elution.  This is achieved using tangential flow membranes.  The media flows tangential 
to a porous membrane containing pores of 10 um in diameter.  Water, along with 
molecules smaller than the membrane pores, cross over to the filtrate of the membrane 
while larger than 10 µm molecules remain in the retentate (Ward and Swiatek, 2009).  
The total media volume and NaCl concentration of the retentate will decrease in 
preparation for lyophilization. 
 To visualize the effectiveness of the purification protocol, a SDS-PAGE gel was 
performed using rcTSH.  Total volume for each well of the Mini-Protean precast gels  
(BioRad 456-1044) are 50 µl so to avoid overfilling the wells, loading samples were 
kept to a 45 µl volume.  The electrophoresis buffer concentrate (BioRad 161-0732) 
required a 1:3 dilution accounting for 10 µl of the preparation.  Adding 2 µl of loading 
dye diluted at a 1:5 ratio with DI water leaves 33 µl for the sample.  A total of 2100 ng 
of rcTSH was present in the 33 µl.  The concentrations of rcTSH were measured by 
chemiluminescence (Siemens Immulite 1000) with canine specific reagents (Siemens 
LKKT5).  Preparations were loaded by pipette into the center wells flanked by molecular 
weight markers (BioRad 161-0324).  Power settings (200V, 120mA, 24W for 30 
minutes) applied to the gel were based upon Bio-Rad's recommendations for the  
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electrophoresis unit. 
 Upon the completion of electrophoresis, the gel was removed from the unit and 
rinsed with deionized (DI) water.  The gel was subsequently stained with Coomassie 
Blue (BioRad 161-0786) according to the manufacturer’s specifications.  The result of 
the stain is illustrated in figure 4.  The technique of electro-elution was performed on the 
stained gel.  Squares of the gel were excised from each lane in which rcTSH was loaded 
into the well.  Gel slices were pooled together according to their vertical location in each 
lane and placed into an electro-elution chamber provided with the Electro-Eluter 
(BioRad 165-2976).  The six chambers filled with gel slices were placed into the 
electrophoresis unit and exposed to an electrical current which removed the Coomassie 
stain as well as residual SDS from the gel and the chamber through a dialysis membrane.  
The dialysis membrane retained the larger rcTSH in the electro-elution chamber which 
was no longer embedded in the polyacrylamide gel. 
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 Figure 4.  Coomassie Blue Stain of rcTSH on SDS-PAGE Gel.  Concentrations of rcTSH 
present at the different molecular weight ranges.  Most of the rcTSH fell between 20K and 35K 
could be due to varying carbohydrate structures. 
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 The buffer, removed from the electro-elution chambers, was measured for TSH 
immuno-activity providing the concentrations present at each vertical step.  The darkest 
band at 17K most likely represent the separated α and β chains which are produced 
individually during the baculovirus expression.  Dimerization of the two chains occurs as 
a post translation event.  The bulk of the rcTSH falls between 20K and 31K with the 
variance in size likely due to the degree of glycosylation present on the individual rcTSH 
molecules.  Another consideration is the position of the rcTSH molecules as migration 
down the gel occurs.  If the lengthwise position of the rcTSH molecules is parallel to the 
bottom of the gel during migration, size of the rcTSH molecules will be a larger 
determinant of the final position on the gel.  If the length of the rcTSH molecule is 
perpendicular to the bottom of the gel when power is applied, the molecules will weave 
through the gel as a needle does through fabric seeming smaller in size. 
 
Primary Cell Culture 
 For the primary cell culture experiment, thyroid tissue was collected from 
mongrel beagles at the Texas A&M University Veterinary College and transferred in 
Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% fetal calf serum 
(FCS), 1% L-glutamine, and 2% penicillin-streptomycin.   Tissue was minced with a 
Stadie-Riggs tissue slicer and rinsed three times in DMEM at 75 ml per 3-4 grams of 
tissue.  After rinsing, tissue was placed in an Erlenmeyer flask containing DMEM and 
0.3% collagenase and incubated in a 37° C water bath for 60 minutes while agitated with 
a magnetic stir bar.  Following incubation, the suspension was poured through double 
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thick sterile gauze and into 50 ml conical tubes for centrifugation for 15 minutes at 1000 
x g.  The supernatants were removed and the pellets re-suspended in DMEM and 
combined into one tube.  The pooled tube was centrifuged for 15 minutes at 1000 x g, 
decanted, and re-suspended 3 times to ensure proper washing.  The final pellet was re-
suspended in 20 mL of DMEM and 10% FCS. 
 To prepare for dilution, the concentration of cells in the suspension was 
calculated using a hemocytometer loaded with a solution of 100 µL (0.04%) Trypan 
Blue and 100 µl of suspension.  A final dilution of the cell suspension with DMEM, 10% 
FCS, and 1% L-glutamine to a concentration of 400,000 cells/ml is achieved according 
to the following calculations: 
 
(Total cells) / (# cells/ml) = total ml of final diluted cell suspension  
where: Total cells = (# of cells on grid)*2*10,000*(# ml suspension) 
and:     # cells/ml = number of cells to place in each culture well/ml 
 
One ml was placed in each of 64 culture wells and placed in a 37° C incubator at 95% O2 
and 5% CO2.  This was marked as Day 0 of the culture. 
 On days 2 and 3 of the culture, medium was removed and replaced with 1 ml of 
DMEM, 10% FCS, and 1% L-glutamine.  The media was again removed on day 4 and 1 
mL of serum-free DMEM was added in preparation for treatments on day 5.  On the day 
of the treatments, eights groups (n=8) were formed.  The groups were formed as follows:  
negative control (DMEM), positive control (forskolin), bTSH low, bTSH medium, 
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bTSH high, rcTSH low, rcTSH medium, and rcTSH high doses.  All TSH doses were 
equivalent immunoreactive concentrations as measured by an immunoassay specific for 
cTSH.  The serum-free media from day 4 was removed and replaced with DMEM + 
treatment equaling a total volume of 1 ml.  After 24 hours, media is removed from the 
culture wells and assayed for cAMP (Cayman Chemicals 581001) concentrations.   
 
Static Tissue Culture 
 Bovine thyroid tissue was collected at slaughter from the Texas A&M University 
Rosenthal Meat Science Center and transported to the lab in Krebs-Ringer Bicarbonate 
(KRB) buffer with 5% bovine serum albumin (BSA).  Thyroid tissue was cut into 
approximately 100 mg slices using the Stadie-Riggs tissue slicer and placed into 13 x 
100 glass culture tubes with 8 mL of KRB+BSA and incubated in a 37° C water bath 
(Precision).  Media was collected and replaced every 20 minutes for 1 hour (4 wash 
collections).  Treatment protocols were developed for four groups (n=5): control (media 
only), 1,600 ng rcTSH, 8,000 ng rcTSH, and 16,000 ng rcTSH.  After the fourth 
collection of media, treatments were administered so the total ng of rcTSH was 
contained in 8 mL of KRB+BSA.  Treatment media was collected every 20 minutes for 
1 hour (3 treatment collections).  Tissue cultures were again washed with media every 20 
minutes for 1 hour (3 wash collections).  Forskolin enriched media (8 ml) was applied to 
the tissue cultures every 20 minutes for 40 minutes (2 forskolin collections).  The final 
wash was performed every 20 minutes for 40 minutes (2 wash collections).  Every 
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incubation period was performed in a 37° C water bath (Precision).  All collections were 
assayed for T4 (Siemens Immulite 1000, Reagent LKCT5) concentrations. 
 
Perifusion 
 Bovine thyroid tissue was collected at slaughter in the Texas A&M University 
Rosenthal Meat Science Center and transported to the lab in KRB buffer with 5% BSA.  
The perifusion system (Endotronics, Inc., Coon Rapids, MN) was immediately turned on 
to fill tubing with media and to reach a temperature of 37˚ C prior to placing tissue in 
chambers.  After removing non-thyroidal tissue, 50 mg slices were loaded into the 
perifusion chambers.  Once the chambers were loaded onto the perifusion system with 
afferent and efferent tubing connected, KRB+BSA media was pumped at a rate of 1 
ml/min.  Tubes (13x100) were used to collect 10 ml fractions.  An initial wash step was 
performed by continuing to run media for 60 minutes with collection of media at 10 
minute intervals to allow any T4 released by the thyroid tissue due to handling would 
settle to a baseline.  The treatment phase consisted of introducing the treatment dose via 
an injection port on the afferent tubing located proximal to the tissue chamber with: 
media (control) (n=4), 25,000 ng bTSH (n=2), and 25,000 ng rcTSH (n=2).  Treatments 
were slowly injected into the injection hub at the perifusion chambers at the 60 minute 
interval.  Thyroid tissue was allowed to return to non-stimulatory, baseline T4 release.  
Forskolin induced release of T4 was performed at minute 140 to illustrate that the tissue 
was viable at the end of the experiment.  Each afferent tube was placed into a flask of 
stock forskolin diluted at 1 to 1000 with media and run for 20 minutes.  A final wash 
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step was performed for 40 minutes to return T4 release to a non-stimulated 
concentration.  All fractions were measured for T4 concentration (Siemens Immulite 
1000, Reagent LKCT5) 
 
RESULTS 
 
Primary Cell Culture 
 On day 5 of the cell culture, before the treatment dosages were given, each well 
was observed under a microscope to view the progress of the culture.  All wells 
displayed good cell division and growth.  Cells could be found dispersed within the well 
while others would form circular structures as if a cell-thick slice from a thyroid follicle 
were taken and placed on the slide.  No fully intact thyroid follicles were observed. 
 Statistical analysis of the data was two-fold: utilizing the ANOVA table to 
analyze the hypothesis that the means of the treatment groups were statistically similar 
and, if the ANOVA table demonstrated a significant difference in the means, the 
Tukey’s W test would determine which data groups were significantly similar and 
different.  ANOVA analysis determined the group means were not similar (P<0.05) 
thereby rejecting the null hypothesis that all means were equal.  Figure 5 demonstrates 
the means of the treatment groups as a bar graph.  The only treatment group with a 
higher expression concentration of cAMP from the media-only negative control was the 
lowest rcTSH dose.  All other groups, including the positive control, had a mean  
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 Figure 5.  Bar Graph of cAMP Production by Cultured, Canine Thyroid Cells.  Presented is a 
bar graph displaying the average means of cAMP production by each treatment group.  Vertical 
bars represent the standard error of the means.
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Table 2.  Comparison Between Primary Cell Culture Treatment Groups.  Red squares 
indicate a significant difference (P<0.05) between the two treatment groups.  The 
relationship between the significantly different groups is provided in each square. 
 
Neg. 
Control 
Pos. 
Control 
Low bTSH Med bTSH High bTSH Low rcTSH 
Med 
rcTSH 
High 
rcTSH 
Neg. 
Control 
 NC>PC  NC>bTSH     
Pos. 
Control 
NC>PC  bTSH>PC  bTSH>PC rcTSH>PC rcTSH>PC  
Low 
bTSH 
 bTSH>PC    rcTSH>bTSH   
Med 
bTSH 
NC>bTSH     rcTSH>bTSH   
High 
bTSH 
 bTSH>PC    rcTSH>bTSH   
Low 
rcTSH 
 bTSH>PC rcTSH>bTSH rcTSH>bTSH rcTSH>bTSH  Low>Med Low>High 
Med 
rcTSH 
 bTSH>PC    Low>Med   
High 
rcTSH 
     Low>High   
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response to treatment lower than the negative control.  Table 2 displays which treatment 
groups were different (P<0.05) and the relationship between the two different values. 
 
Static Tissue Culture 
 Upon initiation of the water bath incubation, water temperature measured to 
37°C and all tissue slices were set appropriately in the culture tubes with equivalent 
amounts of media.  During the treatment phase of the experiment where TSH was 
exposed to the tissue, increased temperature of the water bath was observed over a one 
hour period.  Also, a rack of tubes had been added to the water bath during the one hour 
period increasing the water level.  This resulted in elevating the culture tubes out of the 
rack and into the water bath exposing those tubes to fresh water.  Any displaced tubes 
were secured back into the rack while media was immediately changed in all tubes and 
transferred into another water bath set to 37° C. 
 Performing the same statistical procedures as done on the cAMP data, the 
ANOVA analysis revealed significant differences (P<0.05) in the means at the first, 
third, fourth, sixth, and ninth media-only incubations.  The treatments for the entire 
course of the experiment are represented in figure 6 as line graphs.   
 The groups which were significantly different (P<0.05) are listed in table 3 for 
the individual incubation stages.  On the first, third, and fourth media-only incubations, 
the low rcTSH dose averaged a significantly greater response than the high dose.  The 
sixth and ninth media-only incubations resulted in the control group being significantly 
greater than the high and medium TSH dosage, respectively.  One caveat to keep in  
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 Figure 6.  T4 Release by Bovine Thyroid Tissue in Static Culture.  The average means of the 
treatment groups at each point where media was changed.  Vertical bars represent the standard 
error of the means. 
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Table 3.  Comparison Between Static Culture Treatment Groups.  Red squares indicate a 
significant difference (P<0.05) between the two treatment groups.  The relationship 
between the significantly different groups is provided in each square. 
 First Media Third Media Fourth Media Sixth Media Ninth Media 
Control    Control>High Control>Med 
Low rcTSH Low > High Low > High Low > High   
Med rcTSH     Control>Med 
High rcTSH Low > High Low > High Low > High Control>High  
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mind, some cultures were contaminated and data may be skewed and should be 
interpreted with caution as to significance. 
 
Perifusion 
 This experiment was designed to compare control, bTSH, and rcTSH with each 
group consisting of data from 4 perifusion chambers.  Unfortunately, at the time of the 
experiment, one fractionator was inoperable allowing for only two replicates of bTSH 
and rcTSH.  With such small sample sizes for the TSH treatments, the weight behind a 
statistical analysis would not produce valid statistical inference.  It was decided to use 
the data to manufacture a graphical representation of the perifusion experiment to 
determine the relationship between the stimulatory actions of bTSH and rcTSH.  Figure 
7 depicts the results from the perifusion experiment.  The baseline T4 expressions by the 
three groups before applying the treatments are not equal.  To allow for a more 
subjective comparison, figure 8 displays same lines from figure 7 shifted so the baseline 
T4 before treatments are all equal.  This provides a basal starting point for the 
experimental groups.  Figure 8 shows a small elevation in T4 expression by the control 
group followed by a greater response by rcTSH with the greatest increase observed by 
the bTSH treatment.  Forskolin injection resulted in the expression of T4 by all groups 
providing evidence of viable tissue throughout the experiment. 
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 Figure 7.  T4 Release by Bovine Thyroid Tissue in Perifusion Culture.  Solid lines represent 
the T4 release by the thyroid tissue while broken lines represent the TSH concentration in the 
media at the time of release.  Even though control concentrations are greater than rcTSH at most 
all time points, it is due to the greater baseline T4 release before stimulation.  The slight rise in 
T4 concentration experienced by the control at the time of the treatment dose could be attributed 
to the added pressure applied to the tissue by the force of the treatment injection into the 
injection port located on the afferent tubing. 
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 Figure 8.  Line Graphs from Figure 7 with Normalized Baseline T4 Release.  By shifting all 
line graphs so the baseline T4 before stimulation are equal, better visual representations of the 
treatments when compared to the control are given. 
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DISCUSSION 
 
 In performing in vitro investigations on a possible pharmaceutical agent, the time 
and expenses to house live subjects are removed and replaced by uncertainties of 
replicating a true in vivo experience.  In this day and age, it is always beneficial from an 
animal standpoint to do as much as possible before using live animals in research.  
Results should be analyzed with caution when using in vitro models as negative results 
in an experiment do not necessarily translate into a faulty product but rather the 
consequence of improper procedure or technique. 
 The cAMP response to TSH stimulation resulted in inverted data where the 
media-only negative control was greater in cAMP concentration in all but one (low dose 
rcTSH) treatment.  Past research using dispersed thyroid cell cultures yielded thyroid 
cells with cAMP activity unaffected by TSH stimulation as well (Rapoport, 1976).  A 
gentler approach was eventually utilized to maintain fully intact or, at a minimum, very 
large fragments of thyroid follicles to place onto cell culture plates to develop into full 
monolayer cell cultures.  With tight junctions remaining intact and an extended length of 
time to culture before initiating treatments, monolayer thyroid follicular cells retained 
the sensitivity to TSH binding by responding appropriately with cAMP production 
(Roger et al., 1997).  Dispersed thyroid cells cultured for 5 days before treatment 
produced unexpected results not consistent with the varying doses of TSH 
administration.   
 Other possible variables attributing to the inconsistencies of the cell culture 
experiment include: the extra-follicular cells that were also plated in the culture as 
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cellular dispersion with collagenase did not discern between cell types and some of the 
experimental subjects were positive for heartworms.  The non-follicular thyroid cells 
requisitioned valuable resources reserved for the follicular cells while producing data 
that did not meet expectations.  The movements of the heartworm microfilaria present in 
the culture plates would mechanically inhibit the attachment and growth of the cell 
culture.  Ultimately, the measurable endpoint of rcTSH administration will be T4 release 
by the thyroid.  For this reason, the cell culture experiment was not repeated and T4 
release by intact thyroid tissue sample under different culture conditions was examined. 
 The static culture experiment was the first investigation as to the T4 output by 
thyroid tissue when exposed to rcTSH.  While not all tubes were ejected from the rack, 
all were exposed to elevated water temperature for at least 30 minutes.  Elevated 
temperatures, exposure to fresh water, or improper media could explain the lack of 
response by the thyroid tissue to TSH and forskolin exposure as the maintenance of 
viable tissue was not executed.  As cell death occurs due to high temperatures, hypotonic 
solutions, or lack of nutrients, any stores of molecules (i.e. proteins, steroids, etc.) could 
be released explaining the presence of T4 in the incubation media even though no 
response to stimulating agents appeared to occur. 
 Perifusion experiments were performed in parallel with the static culture.  The 
added control of the different variables during perifusion over static culture was justified 
in not repeating the static culture experiment.  Not obtaining statistical analysis was 
unfortunate; however, the graphical representation provided motivation for future in vivo 
experimentation.  While response was not as great as bTSH, rcTSH did stimulate the 
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bovine thyroid tissue housed in the culture chambers to release T4.  Since culture media 
was used to inject a treatment sample into the control chambers, the slight rise and 
decline in T4 observed by the control might be attributed to the mechanics of the 
injection.  As fluid was injected into the chambers, pressure was added which could 
cause a mechanical release of T4 from the thyroid tissue housed in the chamber.  This is 
quite different from a stimulatory reaction by the thyroid tissue to the presence of a 
thyrotropic hormone.  To distinguish between the amount of T4 release caused by 
injection force and TSH stimulation, the difference between the control T4 release curve 
and that of the treatments represent TSH stimulatory effects. 
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CHAPTER III 
IN VIVO TRIALS 
 
???????? 
 
The efficacy of rcTSH was tested in vivo utilizing goldfish and rat bioassays as a 
prelude to performing the endpoint in vivo experiments in the canine.  Bioactivity of 
rcTSH was measured against bTSH which was considered the “Gold Standard” for 
performing a TSH stimulation test.  Goldfish, rats, and canine, bloodhound crossbreeds 
were given injections of exogenous TSH in separate experiments to determine if rcTSH 
and bTSH were similar in eliciting T4 responses compared to controls (saline injected). 
The goldfish assay performed by Dr. Thomas Miller (Zoology Department, 
Texas A&M University) resulted in similar T4 response profiles between bTSH and 
rcTSH.  The glaring difference was the increased amount of rcTSH needed to equal the 
same T4 release caused by bTSH.  Approximately five times the dose was needed to 
generate the equivalent T4 response using rcTSH compared to bTSH (Miller, 2011). 
For the rat bioassay, equal doses of bTSH and rcTSH were given to rats of 
approximately equal sizes (50g) with post injection blood collections at five hours.  
Activity at the two doses (5,000 ng and 10,000 ng) were compared resulting in similar 
(P>0.05) responses by the groups given exogenous TSH (5000 ng rcTSH mean=4.45, 
5000 ng bTSH mean=5.19, 10000 ng rcTSH mean=5.76, 10000 ng bTSH mean=6.63) 
with significantly different (P<0.05) responses between treatment groups and the control 
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group (mean=2.96).  Even though exogenous treatment (TSH) groups were different 
from control (P<0.05), rcTSH treatments had consistently lower T4 response as 
compared to the bTSH. 
The canine experiment will dictate the true future of rcTSH as a possible FDA 
approved pharmaceutical to be used in the diagnosis of canine hypothyroidism.  As in 
the rat bioassay, canines were given equal immunoreactive doses of rcTSH and bTSH to 
be compared to each other and against a control group at post injection blood collection 
times of 2, 4, 6 ,and 8 hours.  Statistical analysis proved T4 release responses to rcTSH 
(2 hour mean=2.775, 4 hour mean=4.138, 6 hour mean=3.728) and bTSH (2 hour 
mean=3.435, 4 hour mean=5.398, 6 hour mean=5.598) were significantly similar 
(P>0.05) while significantly different (P<0.05) to the control group (2 hour mean=1.525, 
4 hour mean=1.465, 6 hour mean=1.558).  At the eight hour time frame, there was not a 
significant difference (P>0.05) observed between the control group (mean=1.70) and the 
rcTSH group (mean=2.93).  This time frame falls outside the normal TSH stimulation 
protocol of drawing a post injection sample at 4-6 hours. 
The rat and the canine experiments reveal that rcTSH is similar (P>0.05) to the 
“Gold Standard” bTSH in T4 response.  Further steps will be pursued for FDA approval 
as an approved, veterinary diagnostic tool for determining hypothyroidism in the canine. 
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INTRODUCTION 
 
 For the last 30 years, baculovirus mediated recombinant protein expression has 
provided an alternative to producing pharmaceutical agents which emulate their 
endogenous homologues in immuno- and bio- activity (Jarvis, 2009). With the ability to 
accept codon optimized RNA encoding for the POI in addition to performing 
mammalian glycosylation, insect cells are programmed by a baculovirus to manufacture 
a foreign glycoprotein in large quantities which will stimulate a physiologic reaction 
from the target cells.  This technology offers a solution for the veterinarian to increase 
the accuracy of diagnosing true canine hypothyroidism. 
 Hypothyroidism, an endocrinopathy in the canine, represents a common yet often 
misdiagnosed disease to the veterinarian (Graham, 2009).  Clinical signs along with a 
battery of serological tests (i.e. T3, T4, Free T4, TSH) provides insight to the functional 
status of the thyroid gland; however, not all the necessary information to make a firm 
diagnosis will be received at times.  To abate this concern, TSH stimulation test would 
quantify the patient's thyroidal output after injection with exogenous TSH.  Once 
considered the standard protocol for diagnosing canine hypothyroidism, the TSH 
stimulation test was performed using bTSH.  A comparison between serum T4 
concentrations before and 4-6 hours after the bTSH injection would reveal if the thyroid 
gland reacted appropriately to the bolus of bTSH (Panciera, 1999).  With bTSH no 
longer approved for veterinary use and the elevated expense of rhTSH, veterinarians are 
  
62 
forced to base decisions on "snapshots" of thyroid function by submitting serum from 
random blood draws for thyroid hormone assays. 
 Baculovirus expression of rcTSH could provide valuable information to aid in 
the diagnosis of canine hypothyroidism.   Cells from Spodoptera frugiperda of the order 
Lepidoptera are infected by a baculovirus containing recombinant DNA.  Wild-type 
baculovirus infection will force the insect cells to produce the protein, polyhedrin, in 
large quantities.  Substitution of the DNA encoding for polyhedrin with the codon 
optimized sequence for both α and β chains of cTSH located on a designer plasmid 
occurs via homologous recombination.  Insect cells successfully infected will lack the 
visibile presence of the polyhedrin protein and are subsequently cultured for rcTSH 
expression. 
 The media harvested after culture will contain not only rcTSH but other by-
products of cellular protein translation.  The unwanted material must be removed in 
order to isolate the rcTSH before injection else any foreign proteins might cause an 
anaphylactic response.  One objective for this experiment was establishing a purification 
protocol to provide a pharmaceutical agent safe for injection. 
 Upon the purification of rcTSH from the cell culture media, the major objective 
to determine and compare the ability of rcTSH and bTSH to elicit T4 release from the 
thyroid gland using the TSH stimulation test protocol was pursued.  Three bioassays 
were developed for this comparative study: goldfish, rats, and canine species.  The 
goldfish bioassay would be used for an alternate publication so the TSH stimulation test 
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was not performed.  Instead, dose response curves were generated for rcTSH and bTSH 
for comparison. 
 
MATERIALS AND METHODS 
 
Expression of rcTSH 
Filed by Jaques and Jarvis (2009, 2010) , United States patents US 7,479,549 B2 
and US 7,838,492 B2 protects the methods of production and use of rcTSH as proposed 
by inventors Dr. John (Scott) T. Jaques and Dr. Donald L. Jarvis.  The patents detail the 
codon optimizations, alterations made in the codon sequences of amino acids, used to 
maximize production of rcTSH α and β chains by lepidopteran cells.  Also discussed in 
the patents are the various cell lines infected by the baculovirus, AcP(+)DIEcTSHA/B, 
each of which providing individual post-translational glycosylation modifications. 
To summarize, plasmids containing rcTSH DNA undergo homologous 
recombination with the baculovirus effectively exchanging the polyhedron encoded 
region for the α and β chains of rcTSH DNA.  The baculovirus infects the lepidopteran 
cells instructing cellular mechanisms to produce rcTSH, not polyhedron.  The infected 
cells are cultured with fresh medium for 5 days.  Centrifugation removes the cells from 
the culture media containing rcTSH.  Expression of rcTSH is provided by Expression 
Systems, Woodland, CA. 
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Purification of rcTSH 
Frozen (80˚C) media containing rcTSH remained refrigerated at 3°C during 
thaw.  The pH of the media was elevated to 9.5 using NaOH.  The media was then 
centrifuged at 3000 rpm for 15 minutes.  After pouring through a glass wool filter to 
capture sediment formed during centrifugation, the supernate is applied to an AEX 
(Column-Kontes Chromaflex 420830-3020, Resin-GE Healthcare HiTrap Capto Q) 
column.  The cationic charge of the stationary phase attracts molecules with negative 
charges in a 9.5 pH environment (Zhu et al., 2005).  With an approximate pI of 8.5 
(work perform by Dr. Evan Shave of Dr. Vigh’s lab, Chemistry Department, Texas 
A&M University), most rcTSH will not bind to the column.  The column was washed 
with three column volumes of running buffer to collect rcTSH suspended in the mobile 
phase on the AEX column. 
 The harvested flow through media receives acetic acid to lower the pH to 5.0.  
The adjusted media is then applied to a CEX (Column-Kontes Chromaflex 420830-
3020, Resin-GE Healthcare HiTrap Capto S) column.  The rcTSH will retain a positive 
charge and adsorb onto the negatively charged groups on the cation resin (Zhu et al., 
2005).  Three column volumes of buffer remove material suspended in the mobile phase 
of the CEX.  To desorb the rcTSH from the CEX functional groups, a NaCl solution is 
applied to the CEX in an increasing molar gradient. 
 The final step in the purification process is to remove the NaCl.  The media flows 
tangential to a porous membrane containing pores of 10 µm in diameter.  Water, along 
with molecules smaller than the membrane pores, cross over to the filtrate of the 
  
65 
membrane while larger than 10 um molecules remain in the retentate (Ward and 
Swiatek, 2009).  The total media volume and sodium chloride concentration of the 
retentate will decrease in preparation for lyophilization. 
 To visualize the effectiveness of the purification protocol, SDS-PAGE and 
western blot gel protocols are performed in accordance with the Mini-PROTEAN 3 Cell 
(Bio-Rad 165-3301) system.  Multiple sample types were analyzed including: separated 
α and β chains of bTSH (Sigma), bTSH (Sigma), de-glycosylated bTSH (Sigma), bTSH 
(National Institute of Health (NIH)), and rcTSH (SWT-4).  Separation and de-
glycosylation of bTSH was performed by Dr. Thomas Miller of Dr. Duncan McKenzie's 
lab for an alternate publication.  Subsequent to loading the samples into the wells of the 
Mini-Protean precast gel (Bio-Rad 456-1044), all were measured for TSH 
immunoactivity by chemiluminescence (Siemens Immulite 2000) with veterinary canine 
reagents (Siemens LKKT5). Once the TSH concentrations were determined, calculations 
were performed to compute the ratio of sample, buffer (including SDS), loading dye, and 
water so all preparations contained approximately the identical, total milligram amount 
of immunoreactive TSH.  Total volume for each well of the Mini-Protean precast gels 
(Bio-Rad 456-1044) are 50 µl so to avoid overfilling the wells, loading samples were 
kept to a 40 µl volume.  Electrophoresis buffer concentrate (Bio-Rad 161-0732) required 
a 1:3 dilution accounting for 10 µl of the preparation.  Adding 2 µl of loading dye 
diluted at a 1:5 ratio with DI water leaves 28 µl for the sample.  Depending on sample 
concentration, the total volume needed to load a uniform amount of mg TSH onto the gel  
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is supplemented with DI water.  Preparations were loaded by pipette into duplicate wells 
of two gels sharing the same electrophoresis chamber.  Power settings (200V, 120mA, 
24W for 30 minutes) applied to the gel were based upon Bio-Rad's recommendations.  
Due to an outage of an upright refrigeration unit, electrophoresis was performed at room 
temperature instead of a refrigerated environment. 
 Silver staining (Bio-Rad 161-0447) one of gels will present a picture of the 
proteins present in each sample according to their size dependent migration.  The silver 
staining protocol was followed as instructed by the Bio-Rad handbook.  Figure 9 
demonstrates how effective the ion exchange columns and the tangential flow membrane 
were in isolating rcTSH from the culture media.  The rcTSH sample, loaded on the far 
right lane, contains three distinct bands: two lower molecular weight bands possibly 
representing the separate α and β rcTSH subunits and a band of higher molecular weight 
material possibly representing intact, glycosylated rcTSH molecules.  
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 Figure 9.  Silver Stain of rcTSH on SDS-PAGE Gel.  Silver stain of SDS-PAGE gel loaded 
with samples (from left to right): molecular weight marker, bTSH α and β subunits(Sigma), 
bTSH (Sigma), de-glycosylated bTSH (Sigma), bTSH (NIH), and rcTSH (SWT-4). 
  
68 
 To determine if the higher molecular weight band is rcTSH, a western blot is 
performed on the duplicate gel.  The proteins from the unstained gel were transferred to 
the western blot membrane using an electrophoretic transfer cell (Bio-Rad 170-3930) for 
the Mini-Protean 2 Cell electrophoresis unit.  Antibodies to cTSH acquired from 
Siemens were diluted with phosphate buffered saline (PBS) at a 1:1000 dilution for use 
with the western blot reagents (Vector Labs Vectastain ABC-AmP).  Figure 10 shows a 
distinct band which developed in the same, approximate location as the suspected rcTSH 
band in the silver stain gel.  Due to the separate expression of rcTSH α and β subunits 
during culture, the expectation to visualize bands at molecular weights on the silver stain 
for the intact rcTSH and subunits while development of a band on the western blot for 
only the intact rcTSH molecule were met.  Also note that cTSH antibodies did react with 
bTSH as demonstrated by the presence of bands on the western blot in the Sigma, de-
glycosylated Sigma, and NIH bTSH lanes.
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Figure 10.  Western Blot of Duplicate SDS-PAGE Gel from Figure 9. 
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Goldfish 
 Thomas Miller, a former graduate student (PhD) of Dr. MacKenzie’s Lab in the 
Zoology Department at Texas A&M University and I assisted one another while we 
performed our experiments for our research.  While evaluating the biological activity of 
different TSH preparations (bTSH (Sigma), bTSH(NIH), rcTSH (SWT-4), Thyrogen 
(hTSH)) in red drum and goldfish, the now Dr. Miller helped with my project by 
utilizing rcTSH as a source of exogenous TSH with a glycosylation pattern that differed 
from that of bTSH.  A comparison between the bioactivity of rcTSH and bTSH was 
performed by injecting intraperitoneally (IP) multiple groups of goldfish (n=7) with 
varying doses of bTSH (0.1-21.5 ir-ng/µl) or rcTSH (5-100 ir-ng/µl) and harvesting 
blood at 5 hours post injection for plasma T4 concentration determination (Miller, 2011). 
 
Rodent 
 Black and white hooded rats were donated by Dr. George Stoica’s Lab 
(Veterinary Physiology and Pharmacology, Texas A&M University) were randomly 
assigned into groups (n=10) to receive either media for control (saline), 5,000 ng of 
bTSH, 10,000 ng of bTSH, 5,000 ng of rcTSH, or 10,000 ng of rcTSH.  Treatment 
injections were given IP.  Blood was harvested 5 hours post IP injection into sterile red 
top tubes (Monoject).  Serum T4 (Siemens Immulite 2000, Reagent L2KCT6) 
concentrations were determined after centrifugation of the blood collection tubes for 15 
minutes at 2500 rpm.  All rats weighed approximately 50g. 
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Canine 
 Twelve hound crossbreeds were procured from the Texas Department of Justice 
and housed at the Texas A&M University Laboratory Animal Resources and Research 
(LARR) facility.  Canines were fed twice every 24 hours and given water ad lib.  After 
two weeks of acclimation, an IV catheter was placed cephalically on each dog on the 
morning of the experiment.  Once all catheters were place, blood samples were drawn 
for general health chemistries and hypothyroid screens.  Immediately following the 
baseline blood draw, treatments were injected through the catheter port of saline (n=4), 
3,000 ng/kg bTSH (n=4), or 3,000 ng/kg rcTSH (n=4).  Blood samples were taken at 0, 
2, 4, 6, and 8 hours post treatment injections into red top tubes (Monoject).  The tubes 
were centrifuged for 15 minutes at 2500 rpm to separate serum from the red blood cells.   
T4 concentrations were subsequently measured using canine specific regents (Siemens 
Immulite 2000, Reagents L2KCT6). 
 
RESULTS 
 
Goldfish 
 The response to bTSH and rcTSH in the production of T4 five hours after 
injection paralleled one another but at a different dosage frame in goldfish.  At every 
point, the rcTSH required a larger dose to evoke the same T4 response as the smaller 
bTSH dose.  For example, bTSH at a dose of approximately 21.5 ir-ng/µl elicited a 
slightly larger T4 response than rcTSH at 100 ir-ng/µL as shown in figure 11 (Miller,  
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 Figure 11.  Response of Goldfish Thyroid Tissue to bTSH and rcTSH.  Dr. Miller’s data 
compares the response of goldfish thyroid tissue to bTSH and rcTSH (SWT-4).  While the line 
graphs representing the T4 release to TSH stimulation parallel one another, the rcTSH required 
much larger doses than bTSH to elicit the same response (Miller, 2011). 
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2011).  While the potency of rcTSH was not equal to that of bTSH, a response to rcTSH 
by goldfish thyroid tissue was evident. 
 
Rodent 
 Like the goldfish, data gathered from an exogenous TSH stimulation performed 
on rats produced encouraging findings.  Using ANOVA analysis rejected the null 
hypothesis that all means were similar (P<0.05).  The Tukey’s W Procedure was 
performed to determine which groups were similar.  In comparison of the 5,000 ng dose, 
both rcTSH and bTSH were significantly different (P<0.05) from the control group 
while being significantly similar (P>0.05) to each other as shown in figure 12.  Analysis 
of the 10,000 ng dose was not different from the 5,000 ng dose treatment: significant 
differences (P<0.05) were observed between groups receiving TSH and the control 
(saline) group with similar stimulatory effects (P>0.05) between groups receiving 
exogenous TSH which is shown in figure 13.  In both cases, the mean T4 response from 
bTSH was greater than rcTSH but not significantly different (P>0.05). 
 Figures 14 and 15 represent the serum TSH concentrations for the 5,000 ng and 
the 10,000 ng dosed groups, respectively.  No similarities (P<0.05) existed between the 
treatment groups of the 5,000 ng dose group.  In the 10,000 ng dose individuals, the 
groups receiving TSH were similar (P>0.05) in serum TSH concentration with both 
being greater (P<0.05) than the control. Determining TSH concentration after injection is 
not a top priority in this research.  When glycosylation studies are initiated will longevity 
in circulation be a more relevant consideration.
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 Figure 12.  Response of Rat Thyroid Tissue to 5,000 ng of bTSH and rcTSH.  Both TSH 
analogs were significantly greater (P<0.05) than control while significantly similar to each other 
(P>0.05). 
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 Figure 13.  Response of Rat Thyroid Tissue to 10,000 ng of bTSH and rcTSH. The means of 
T4 response in rats exposed to 10,000 ng of exogenous TSH performed in parallel to the groups 
depicted in figure 9.  Similarly, TSH groups were significantly similar to one another (P>0.05) 
but significantly different from control (P<0.05). 
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 Figure 14.  Serum TSH Concentrations of Rats from Figure 12.  Differences were 
observed between all treatment groups (P<0.05).
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 Figure 15.  Serum TSH Concentrations of Rats from Figure 13.  Both treatment groups 
were greater (P<0.05) than the control and similar (P>0.05) to each other.
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Canine 
  
 Performing TSH Stimulation tests on the species which the recombinant 
hormone was specifically design for brought excitement.  Our husbandry for these test 
animals was arduous as they were not accustomed to walking on a leash and running 
without supervision in a field which was a new and clumsy experience for all 
individuals.  For two weeks, our goal was to acclimate the canines to their new 
surroundings and develop a sense of trust with their new handlers through feedings and 
shared activities to reduce the stress during the experiment. 
 Catheters were placed on all individuals successfully; however, some individuals 
removed their catheters during the course of the experiment.  Any individuals removing 
their catheters were subjected to a blood draw via cephalic venipuncture with a 22 gauge 
x 1 inch needle and 5 ml syringe at collection times.  Attempting to place another 
catheter resulted in a quicker removal of the catheter by the subject.  E-collars were also 
employed to aid in preventing catheter removal. 
 Analysis using ANOVA rejected the null hypothesis that all means were 
significantly similar (P<0.05) leading to the Tukey’s W Procedure.  At the baseline 
sample, the Tukey's comparison resulted in the non-significant difference (P>0.05) 
between all groups indicating a normalized baseline T4 for all individuals.  The serum  
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T4 concentrations at the 2, 4, and 6 hour post injection blood collections did not 
significantly differ (P>0.05) between the treatment groups.  Both groups receiving TSH 
treatments were greater (P<0.05) in T4 response to the injection from control (saline) 
group at all 3 time points.  The only time point where T4 response to a preparation of 
TSH was not significantly different (P>0.05) between control (saline) and a treatment 
group (rcTSH) was at the 8 hour draw. 
 Figure 16 displays the means for serum T4 concentrations for all treatment 
groups at their respective blood draws.  Serum levels of T4 were greater in response to 
bTSH than rcTSH at all time points.  Serum TSH concentrations visualized in figure 17 
are consistently greater for bTSH until hour eight.  The presence of sialic acid on the 
rcTSH molecules could be reason for its elevation over bTSH in serum concentration at 
that blood collection time.
  
80 
 
 Figure 16.  Response of Canine Thyroid Tissue to bTSH and rcTSH.  The mean T4 response 
by canines at various hours after receiving exogenous TSH or control.  At all data points, bTSH 
and rcTSH were significantly similar (P>0.05).  Both exogenous TSH treatments were 
significantly different (P<0.05) from control except for rcTSH at the 8 hour post sampling. 
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 Figure 17.  Serum TSH Concentrations of Canines from Figure 16 
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DISCUSSION 
 
 All in vivo experiments demonstrated similar conclusions: rcTSH does elicit a 
response by thyroid tissue in the species used in the preceding experiments; a greater 
amount of rcTSH is needed to evoke a T4 response equal to that of bTSH; and rcTSH 
was significantly similar to bTSH in causing T4 release.  It was shown in goldfish that 
canine pituitary extract had a statistically equivalent response in T4 stimulation as bTSH 
(Miller, 2011).  Recombinant cTSH was designed by Dr. Jaques to emulate endogenous 
cTSH (at least 98% homology for both α and β chains) with the exception of optimizing 
the nucleic acid sequence to promote a greater expression of rcTSH in lepidopteran cells 
(Jaques and Jarvis, 2010).  Any changes to nucleic acid sequences away from the true 
cTSH sequence in order to increase rcTSH expression could be tested for efficacy by 
utilizing the in vivo methods described in this chapter. 
 The amino acid sequence of rcTSH was designed to mimic endogenous cTSH 
which stimulated T4 production and release to the same efficacy as bTSH in goldfish.  It 
is therefore interesting to observe rcTSH not promoting an increase in serum T4 
concentrations as bTSH.  An obstacle when using insect cells to produce a mammalian 
protein, other than different codon sequences encoding for amino acids, is the 
glycosylation machinery in insect cells do not natively produce the complex 
carbohydrate moieties as mammalian cells.  The enzymes to remove sugars are available 
to the insect cell while the enzymes to build the sugar chains like mammalian cells are 
not (Jarvis, 2003).  Fortunately, methods have been discovered to manipulate insect cells 
to act more mammalian.  Insect cell lines have progressed from Sf9 to SfSWT-
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1/SfSWT-3 and SfSWT-4 each increasing in its ability add complex mammalian 
carbohydrate structures (Shi and Jarvis, 2007).  The rcTSH produced by the SfSWT-4 
cell line was used for all the experiments described in this dissertation due to its ability 
to build complex, biantennary oligosaccharides with terminal sialylation.  Sialic acid 
attached to the termini of an oligosaccharide provides protection to the glycoprotein 
from hepatic removal from circulation as well as a slight negative charge to the molecule 
allowing for an increase in water solubility (Morell et al., 1971).  Endogenous cTSH and 
bTSH, however, contain sulfated termini to which hepatic endothelial and Kupffer cells 
have receptors.  This allows the liver to quickly clear molecules containing a specific 
oligosaccharide chain terminating with sulfonation.  These properties are similar to those 
found LH.  Rapid clearance of these molecules activates a negative feedback at the 
pituitary to release more of LH or TSH which will be quickly cleared again by the liver.  
This equates to pulsatile hormone concentrations in the bloodstream increasing the 
biological effect by the hormones (Strott, 2002). 
 While rcTSH may numerically not incite a T4 response equivalent to bTSH, 
statistically both are stimulatory.  As seen in figure 17, rcTSH remained higher in 
circulation at the 8 hour post injection demonstrating the effectiveness of terminal end 
sialylation of the carbohydrate moieties present on rcTSH.  Further investigation is 
needed to determine the biological activity of rcTSH with sialic acid compared to 
sulfonation of the oligosaccharide termini; however, rcTSH has been shown to have the 
same efficacy as bTSH, but in most cases, not as elevated in T4 response to the 
exogenous challenge. 
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CHAPTER IV 
CONCLUSIONS 
 
 The purpose of these experiments was to determine, using in vitro and in vivo 
techniques, if a recombinant form of cTSH produced by baculovirus achieved the same 
statistical efficacy (release of T4) as the “Gold Standard” bTSH when used as an 
exogenous source for the TSH stimulation test.  Developing techniques to produce 
recombinant sources of protein hormones is essential for disease diagnoses and treatment 
in the health care field.  A protein produced by a baculovirus was approved by the FDA 
as the first recombinant vaccine for acquired immune deficiency syndrome (AIDS) to 
undergo trials (Luckow and Summers, 1988).   No longer can extracts from other species 
be used for fear of disease transmission.  While human medicine spares no expense in 
developing and bringing pharmaceutical drugs to market, the veterinary field is not quite 
as receptive to the high cost of products destined for the use in veterinary health.  
Fortunately, the popularity of pet insurance is on the rise which could provide more 
opportunities for research in customizing pharmaceuticals for the pet industry. 
 To belay cost considerations, a baculovirus capable of infecting cells of the 
Lepidoptera order was used to create a recombinant, glycosylated canine thyroid 
stimulating protein hormone.  This would provide a more direct alternative to aid in 
determining the functional status of the thyroid gland ass compared to performing the 
ancillary tests like T3, T4, and Free T4, to name a few.  Stimulating thyroidal production 
of T4 by rcTSH was compared against an older “Gold Standard” of bTSH which had 
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been used in the past for a TSH stimulation test in the canine which is no longer 
sanctioned by the FDA as a pharmaceutical agent.  The in vitro and in vivo experiments 
designed for the comparative efficacy study demonstrated the similar (P>0.05) potency 
of rcTSH to bTSH in stimulating activity in thyroid follicular cells with the exception of 
the cAMP cell culture and the static tissue culture.  The issues preventing appropriate 
data collection from these two experiments have been addressed; however, the 
alternative testing protocols (perifusion, bioassays) presented offer either greater control 
of variables during the experiment (perifusion system control over media temperature, 
%CO2, %O2, dynamic nutritional delivery) or a viable bioassay providing physiologic 
responses to an exogenous thyroid stimulatory glycoprotein. 
 The choice to investigate rcTSH was decided by the need for a better diagnostic 
tool to identify hypothyroidism in the canine as compared to the current “backdoor test” 
to identify true hypothyroid animals.  Providing a consistent source of TSH with FDA 
approval and the availability of a more improved hormone assay for the measurement of 
canine specific TSH may provide for better and more accurate ways to asses 
hypothyroidism in the canine.  An alternative goal to this research is to lay the 
groundwork for the production of two glycoproteins of similar structure to TSH, bovine 
LH and more importantly bovine FSH.   The use of LH and primarily FSH in the cattle 
industry is quite prevalent in superovulation protocols and as possible treatments for 
conditions inhibiting reproduction such as cystic ovaries. 
 While short term goals have been identified, the scope of this technology can 
benefit in the production of many other hormones (specifically the glycoproteins) in 
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other species whether it is for agriculture or preservation.  Further recombinant 
diagnostic tools could be considered for veterinary as well as human medicine. The 
ability to design specific recombinant proteins could also provide the basis for creating 
antibodies to develop better hormone assays.   
 From a business perspective, improvements in glycosylation will occur possibly 
producing a more potent ligand resulting in requiring a smaller dose for a physiologic 
response.  Other production consideration addresses the concerns that the metabolic 
strain on the insect cells to produce a mammalian glycoprotein might inhibit the insect 
cells from proper growth and stability.  A new cell line (SfSWT-5) has been developed 
to help address those metabolic concerns (Aumiller et al., 2011).  As baculovirus 
technology advances towards the goal of producing fully glycosylated, recombinant 
mammalian protein hormones at a high yield rate, the impact of this system will continue 
to affect many species in many fields of physiology. 
  
  
87 
LITERATURE CITED 
 
Attali, J. R., D. Darnis, P. Valensi, C. Weisselberg, and J. Sebaoun. 1984. Use of the  
perifusion technique on rat thyroid fragments in the study of thyroid hormone 
secretion: short-term effects of thyrotrophin, theophylline and glucagon. J. 
Endocrinol. 102(1):43-48. 
 
Aumiller, J. J., H. Mabashi-Asazuma, A. Hillar, X. Shi, and D. L. Jarvis. 2011. A new 
 glycoengineered insect cell line with an inducibly mammalianized protein N-
 glycosylation pathway. Glycobiology. 22(3):417-428. 
 
Baneyx, F. 1999. Recombinant protein expression in Escherichia coli. Curr. Opin. 
 Biotechnol. 10:411-421. 
 
Bartalena, L. 1990. Recent achievements in studies on thyroid hormone-binding 
 proteins. Endocr. Rev. 11(1):47-64. 
 
Berggren, K., E. Chernokalskaya, T. H. Steinberg, C. Kemper, M. F. Lopez, Z. Diwu, R.  
 P. Haugland, and W. F. Patton. 2000. Background-free, high sensitivity staining 
 of proteins in one- and two-dimensional sodium dodecyl sulfate-polyacrylamide  
 gels using a luminescent ruthenium complex.  Electrophoresis. 21:2509-2521. 
 
Carrel, A., and M. T. Burrows. 1911. Cultivation in vitro of the thyroid gland. Jour.  
 Exper. Med. 13(4):416-421. 
 
Chiba, K., H. Kobayashi, and K. Wakabayashi. 1997. Isolation and partial  
characterization of LH, FSH, and TSH from canine pituitary gland. Endocr. J. 
44(2):205-218. 
 
  
88 
Daban, J. R., M. Samso, and S. Bartolome. 1991. Use of Nile Red as a fluorescent probe  
 for the study of the hydrophobic properties of protein-sodium dodecyl sulfate  
 complexes in solution. Anal Biochem. 199:162-168. 
 
Dremier, S., M. Milenkovic, S. Blancquaert, J. E. Dumont, S.O. Døskeland, C.  
Maenhaut, and P. P. Roger. 2007. Cyclic adenosine 3’,5’-monophosphate 
(cAMP)-dependent protein kinases, but not exchange proteins directly activated 
by cAMP (Epac), mediate thyrotropin/cAMP-dependent regulation of thyroid 
cells. Endocrinology. 148(10):4612-4622. 
 
Farid, N. R., and M. W. Szkudlinski. 2004. Minireview: Structural and functional  
evolution of the thyrotropin receptor. Endocrinology. 145(9):4048-4057.  
 
Fazekas de St. Groth, S., R. G. Webster, and A. Datyner. 1962. Two new staining  
 procedures for quantitative estimation of proteins on electrophoretic strips.  
 Biochim. Biophys. Acta. 71:377-391. 
 
Goldsmith, S. J. 1975. Radioimmunoassay: Review of basic principles. Semin. Nucl. 
 Med. 5(2):125-152. 
 
Graham, P. A., K. R. Refsal, and R. F. Nachreiner. 2007. Etiopathologic findings of 
 canine hypothyroidism. Vet. Clin. North Am. Small Anim. Pract. 37:617-631. 
 
Graham, P. 2009. Canine hypothyroidism: diagnosis and therapy. In Practice. 31:77-82. 
 
Grau, E. G., L. M. H. Helms, S. K. Shimoda, C. Ford, J. LeGrand, and K. Yamauchi. 
 1986. The thyroid gland of the Hawaiian parrotfish and its use as an in vitro 
 model system.  Gen. Comp. Endocrinol. 61:100-108. 
 
  
89 
Green, E. D., and J. U. Baenziger. 1988a. Asparagine-linked oligosaccharides on 
 lutropin, follitropin, and thyrotropin. I. Structural elucidation of the sulfated 
 and sialylated oligosaccharides on bovine, ovine, and human pituitary 
 glycoprotein hormones. J. Biol. Chem. 263(1):25-35. 
 
Green, E.D., and J.U. Baenziger. 1988b. Asparagine-linked oligosaccharides on lutropin,  
follitropin, and thyrotropin. II. Distribution of sulfated and sialylated 
oligosaccharides on bovine, ovine, and human pituitary glycoprotein hormones. 
J. Biol. Chem. 263(1):36-44. 
 
Greenspan, F. S., and J. D. Baxter. 1994. Pages 162-191 in Basic & Clinical 
 Endocrinology. 4th ed. Appleton & Lange, Norwalk, CT. 
 
Grossman, M., M. W. Szkudlinski, R. Wong, J. A. Dias, T. H. Ji, and B. D. Weintraub. 
1997. Substitution of the seat-belt region of the thyroid-stimulating hormone 
(TSH) β-subunit with the corresponding regions of chorioganadotropin or 
follitropin confers luteotropic but not follitropic activity to chimeric TSH. J. Biol. 
Chem. 272(24):15532-15540. 
 
Hassan, H. A., and R. A. Merkel. 1994. Perifusion model system to culture bovine 
 hypothalamic slices in series with dispersed anterior pituitary cells. In Vitro Cell. 
 Dev. Biol. Anim. 30A:435-442. 
 
Jaques, J. S. T., and D. L. Jarvis. 2009. Recombinant canine thyroid stimulating 
 hormone and methods of production and use thereof. United States Patent: US 
 7,479,549 B2. 
 
  
90 
Jaques, J. S. T., and D. L. Jarvis. 2010. Recombinant canine thyroid stimulating 
 hormone and methods of production and use thereof. United States Patent: US 
 7,838,492 B2. 
 
Jarvis, D. L. 2003. Developing baculovirus-insect cell expression systems for humanized  
recombinant glycoprotein production.  Virology. 310:1-7. 
 
Jarvis, D. L. 2009. Baculovirus-insect cell expression systems. Meth. Enzymol. 
 463:191-222. 
 
Keel, B. A., and H. E. Grotjan Jr. 1989. Pages 204-215 in Microheterogeneity of 
 glycoprotein hormones. CRC Press, Boca Raton, FL. 
 
Kenefick, S. J., and R. Neiger. 2008. The effect of trilostane treatment on circulating 
 thyroid hormone concentrations in dogs with pituitary-dependent 
 hyperadrenocorticism. J. Small Anim. Pract. 49:139-143. 
 
Laurberg, P. 1976. T4 and T3 release from the perfused canine thyroid isolated in situ. 
 Acta Endocinol. 83:105-113. 
 
Luckow. V. A., and M. D. Summers. 1988. Trends in the development of baculovirus 
 expression vectors. Biotechnology. 6:47-55. 
 
Mainini, C. G. 1947. Pregnancy test using the male toad. J. Clin. Endocrinol. 7(9):653-
 658. 
 
 
 
 
  
91 
Mariotti, S. 2011. Normal physiology of the hypothalamic-pituitary-thyroidal system  
and relation to the neural system and other endocrine gland. Accessed March 27, 
2012. http://www.thyroidmanager.org/chapter/physiology-of-the-hypothalmic-
pituitary-thyroidal-system/. 
 
Metcalfe, R. A., C. Findlay, W. R. Robertson, A. P. Weetman, and S. MacNeil. 1998.  
Differential effect of thyroid-stimulating hormone (TSH) on intracellular free 
calcium and cAMP in cells transfected with the human TSH receptor. J. 
Endocrinol. 157:415-424. 
 
Metz, B., G. F. A. Kersten, G. J. E. Baart, A. de Jong, H. Meiring, J. ten Hove, M. J. van  
 Steenbergen, W. E. Hennink, D. J. A. Crommelin, and W. Jiskoot. 2006.  
 Identification of formaldehyde-induced modifications in proteins: Reactions with  
 insulin.  Bioconjug. Chem. 17:815-822. 
 
Miller, T. 2011. Biological activity of thyrotropin in two teleost fish, red drum 
 (Sciaenops ocellatus) and goldfish (Carassius auratus). PhD Diss. Texas A&M 
 Univ., College Station. 
 
Mohorko, E., R. Glockshuber, and M. Aebi. 2011. Oligosaccharyltransferase: The 
 central enzyme of N-linked protein glycosylation. J. Inherit. Metab. Dis. 34:869-
 878. 
 
Mooney, C. T. 2011. Canine hypothyroidism: A review of aetiology and diagnosis. N. 
 Z. Vet. J. 59(3):105-114. 
 
Morell, A. G., G. Gregoriadis, and I. H. Scheinberg. 1971. The role of sialic acid in 
 determining the survival of glycoproteins in the circulation. J. Biol. Chem. 
 246(5):1461-1467. 
  
92 
Neumann, S., B. M. Raaka, and M. C. Gershengorn. 2010. Constitutively active  
thyrotropin and thyrotropin-releasing hormone receptors and their inverse 
agonists. Meth. Enzymol. 485:147-160. 
 
Ott., R. L., and M. Longnecker. 2001. Pages 379-447 in An introduction to statistical  
 methods and data analysis. 5
th
 ed. Duxbury, Pacific Grove, CA. 
 
Panciera, D. L. 1999. Is it possible to diagnose canine hypothyroidism? J. Small Anim.  
 Pract. 40:152-157. 
 
Panciera, D. L., B. J. Purswell, and K. A. Kolster. 2007. Effect of short-term 
 hypothyroidism on reproduction in the bitch.  Theriogenology. 68:316-321. 
 
Patton, W. 2000. A thousand points of light: The application of fluorescence detection  
 technologies to two dimensional gel electrophoresis and proteomics.  
 Electrophoresis. 21:1123-1144. 
 
Pink, M., N. Verma, A. W. Rettenmeier, and S. Schmitz-Spanke. 2010. CBB staining  
 protocol with higher sensitivity and mass spectrometric compatibility.   
 Electrophoresis. 31:593-598. 
 
Prudom, C., J. Liu, J. Patrie, B. D. Gaylinn, K. E. Foster-Schubert, D. E. Cummings, M. 
 O. Thorner, and H. M. Geysen. 2010. Comparison of competitive 
 radioimmunoassays and two-site sandwich assays for the measurement and 
 interpretation of plasma ghrelin concentrations. J. Clin. Endocrinol. Metab. 
 95(5):2351-2358. 
 
 
 
  
93 
Pulvertaft, R., J. R. Davies, L. Weiss, and J. H. Wilkinson. 1959. Studies on tissue  
 cultures of human pathological thyroids. J. Pathol. Bacteriol. 77(1):19-32. 
 
Rapoport, B. 1976. Dog thyroid cells in monolayer tissue culture: Adenosine 3’, 5-cyclic 
 monophosphate response to thyrotropic hormone.  Endocrinol. 98(5): 1189-1197. 
 
Raymond, S., and L. Weintraub. 1959. Acrylamide gel as a supporting medium for zone  
 electrophoresis. Science. 130 (3377):711. 
 
Reimers T. J., V. J. Salerno, and S.V. Lamb.  1996. Validation and application of solid-
 phase chemiluminescent immunoassays for diagnosis of endocrine diseases in 
 animals. Comp. Haematol. Int. 6:170-175. 
 
Richards, J. B., and S. H. Ingbar. 1959. The effects of propylthiouracil and perchlorate 
 on the biogenesis of thyroid hormone. Endocrinol. 65(2):198-207. 
 
Roger, P. P., D. Christophe, J. E. Dumont, and I. Pirson, 1997. The dog thyroid primary 
 culture system: A model of the regulation of function, growth and differentiation 
 expression by cAMP and other well-defined signaling cascades. Eur. J. 
 Endocrinol. 137:579-598. 
 
Sasse, J., and S. R. Gallagher. 2009. Staining proteins in gels. Curr. Protoc. Mol. Biol. 
 Supplement 85. 10.6.1-10.6.27. 
  
Shapiro, A. L., E. Vinuela, and J. V. Maizel Jr. 1967. Molecular weight estimation of  
 polypeptide chains by electrophoresis in SDS-polyacrylamide gels.  
 Biochem. Biophys. Res. Commun. 28(5): 815-820. 
 
  
94 
Shi, X., and D. L. Jarvis. 2007. Protein N-glycosylation in the baculovirus-insect cell 
 system. Curr. Drug Targets. 8:1116-1125. 
 
Shorten, P. R., and D. J. N. Wall. 2001. A model of dispersion in perifusion systems. J. 
 Theor. Med. 3:191-211. 
 
Smith, G. E., M. D. Summers, and M. J. Fraser. 1983. Production of human beta 
 interferon in insect cells infected with a baculovirus expression vector. Cell. Mol. 
 Biol. 3(12):2156-2165 
 
Strott, C. A. 2002. Sulfonation and molecular action. Endocr. Rev. 23(5):703-732. 
 
Sugiura, S., and T. Kanamori. 2011. Comparison of substance supply in static and  
 perfusion cultures based on mass transport phenomena. Biochem. Eng. J.  
 57:69-74. 
 
Switzer III, R. C., C. R. Merril, and S. Shifrin. 1979. A highly sensitive stain for 
 detecting proteins and peptides in polyacrylamide gels. Anal. Biochem. 98:231-
 237. 
 
Szkudlinski, M. W., N. R. Thotakura, J. E. Tropea, M. Grossman, and B. D. Weintraub. 
1995. Asparagine-linked oligosaccharide structures determine clearance and 
organ distribution of pituitary and recombinant thyrotropin. Endocrinol. 
136(8):3325-3330. 
 
Szkudlinski, M. W., V. Fremont, C. Ronin, and B. D. Weintraub. 2002. Thyroid-
 stimulating hormone and thyroid-stimulating hormone receptor structure-
 function relationships. Physiol. Rev. 82:473-502. 
 
  
95 
Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from  
 polyacrylamide gels to nitrocellulose sheets: Procedure and some applications.  
 Proc. Natl. Acad. Sci. U.S.A. 76(9):4350-4354. 
 
Uhlenhuth, E., and S. Schwartzbach. 1927. The morphology and physiology of the  
 salamander thyroid gland II. The anterior lobe of the hypophysis as a control  
 mechanism of the function of the thyroid gland. Br. J. Exp. Biol. 5(1):1-5. 
 
van Oers, M. M. 2011. Opportunities and challenges for the baculovirus expression 
 system. J. Invertebr. Pathol. 107:S3-S15. 
 
Vesterberg, O. 1993. A short history of electrophoretic methods. Electrophoresis.  
 14:1243-1249. 
 
Ward, W. W., and G. Swiatek. 2009. Protein purification. Curr. Anal. Chem. 
 5(2):1-21. 
 
Yalow, R. S., and S. A. Berson. 1960. Immunoassay of endogenous plasma insulin in 
 man. J. Clin. Invest. 39(7):1157-1175. 
 
Yang, X., R. A. McGraw, and D. C. Ferguson. 2000a. cDNA of canine common α gene  
and its co-expression with canine thyrotropin β gene in baculovirus expression 
systems. Domest. Anim. Endocrinol. 18:379-393. 
 
Yang, X., R. A. McGraw, X. Su, P. Katakam, W. M. Grosse, O. W. Li, and D. C.  
Ferguson. 2000b. Canine thyrotropin β-subunit gene: Cloning and expression in 
Escherichia coli, generation of monoclonal antibodies, and transient expression 
in the Chinese hamster ovary cells. Domest. Anim. Endocrinol. 18:363-378. 
 
  
96 
Zhu K., J. Zhao, and D. M. Lubman. 2005. Protein pI shifts due to posttranslational  
modifications in the separation and characterization of proteins. Anal. Chem. 
77:2745-2755. 
  
97 
APPENDIX A 
IN VITRO DATA 
 
A1.  Primary Cell Culture Data 
Data Pt. cAMP Data Pt. cAMP Groups (i,j) |Yi - Yj| W-|Yi-Yj|
1a 0.10400 5a 0.09400 1,2 0.01925 -0.00796
1b 0.11000 5b 0.10700 1,3 0.00700 0.00429
1c 0.09300 5c 0.10400 1,4 0.01275 -0.00146
1d 0.10400 5d 0.09000 1,5 0.00563 0.00567
1e 0.09400 5e 0.09500 1,6 0.00763 0.00367
1f 0.08700 5f 0.08500 1,7 0.00525 0.00604
1g 0.10600 5g 0.09100 1,8 0.01063 0.00067
1h 0.10400 5h 0.09100
2,3 0.01225 -0.00096
2a 0.06900 6a 0.09500 2,4 0.00650 0.00479
2b 0.07800 6b 0.10700 2,5 0.01363 -0.00233
2c 0.10200 6c 0.11200 2,6 0.02688 -0.01558
2d 0.08000 6d 0.10100 2,7 0.01400 -0.00271
2e 0.08600 6e 0.11700 2,8 0.00862 0.00267
2f 0.07400 6f 0.11700
2g 0.08100 6g 0.11200 3,4 0.00575 0.00554
2h 0.07800 6h 0.10200 3,5 0.00138 0.00992
3,6 0.01463 -0.00333
3a 0.09500 7a 0.09900 3,7 0.00175 0.00954
3b 0.09100 7b 0.10000 3,8 0.00362 0.00767
3c 0.08200 7c 0.09500
3d 0.10500 7d 0.09100 4,5 0.00713 0.00417
3e 0.09600 7e 0.08800 4,6 0.02038 -0.00908
3f 0.09000 7f 0.10100 4,7 0.00750 0.00379
3g 0.09600 7g 0.09600 4,8 0.00213 0.00917
3h 0.09100 7h 0.09000
5,6 0.01325 -0.00196
4a 0.08800 8a 0.09100 5,7 0.00038 0.01092
4b 0.08600 8b 0.10400 5,8 0.00500 0.00629
4c 0.09800 8c 0.08800
4d 0.09000 8d 0.09200 6,7 0.01288 -0.00158
4e 0.09000 8e 0.08200 6,8 0.01825 -0.00696
4f 0.08600 8f 0.08700
4g 0.08300 8g 0.08900 7,8 0.00537 0.00592
4h 0.07900 8h 0.08400  
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APPENDIX B 
IN VIVO DATA 
 
B1.  Rodent Data @ 5000 ng TSH 
Data Pt. T4 Groups (i,j) |Yi - Yj| W-|Yi-Yj| TSH Groups (i,j) |Yi - Yj| W-|Yi-Yj|
1a 4.17000 1,2 2.23500 -1.07817 0.075 1,2 1.413 0.018101
1b 3.81000 1,3 1.49300 -0.33617 0.046 1,3 0.1497 1.281401
1c 2.33000 0.051
1d 2.38000 2,3 0.74200 0.41483 0.04 2,3 1.2633 0.167801
1e 2.17000 0.072
1f 2.25000 0.049
1g 3.17000 0.043
1h 3.09000 0.043
1i 2.60000 0.071
1j 3.61000 0.05
2a 6.61000 0.067
2b 3.90000 0.123
2c 5.87000 1.97
2d 5.00000 2.8
2e 3.23000 1.83
2f 6.60000 1.42
2g 6.60000 1.44
2h 3.69000 2.32
2i 7.69000 1.3
2j 2.74000 1.4
3a 6.09000 0.328
3b 4.89000 0.225
3c 3.71000 0.27
3d 4.17000 0.126
3e 4.71000 0.165
3f 4.22000 0.153
3g 5.04000 0.156
3h 5.70000 0.341
3i 1.59000 0.047
3j 4.39000 0.226
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B2.  Rodent Data @ 10,000 ng TSH 
Data Pt. T4 Groups (i,j) |Yi - Yj| W-|Yi-Yj| TSH Groups (i,j) |Yi - Yj| W-|Yi-Yj|
1a 4.17000 1,2 3.66900 -1.26978 0.075 1,2 1.0978 -0.60154
1b 3.81000 1,3 2.79800 -0.39878 0.046 1,3 0.7238 -0.22754
1c 2.33000 0.051
1d 2.38000 2,3 0.87100 1.52822 0.04 2,3 0.374 0.122258
1e 2.17000 0.072
1f 2.25000 0.049
1g 3.17000 0.043
1h 3.09000 0.043
1i 2.60000 0.071
1j 3.61000 0.05
2a 3.04000 1.3
2b 3.96000 1.1
2c 7.97000 1.68
2d 7.64000 1.19
2e 7.44000 1.69
2f 8.10000 0.031
2g 8.16000 0.177
2h 9.77000 2.16
2i 3.59000 1.09
2j 6.60000 1.1
3a 2.03000 0.149
3b 2.36000 0.097
3c 2.12000 0.176
3d 5.24000 0.774
3e 9.42000 1.46
3f 6.58000 1.51
3g 7.97000 0.893
3h 6.76000 0.528
3i 8.21000 1.37
3j 6.87000 0.821
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B3.  Canine Data 
Data Pt. 2 hr post 4 hr post 6 hr post 8 hr post
1a 1.79 1.57 1.28 1.25
1b 1.55 1.47 1.45 1.34
1c 1.07 1.17 1.52 1.98
1d 1.69 1.65 1.98 2.23
2a 3.97 6.62 6.88 6.75
2b 2.86 4.47 5 4.59
2c 3.97 6.3 6.65 6.5
2d 2.94 4.2 3.86 2.97
3a 1.84 3.92 4.03 2.65
3b 2.81 3.46 2.9 2.76
3c 2.95 3.69 2.73 2.12
3d 3.5 5.48 5.25 4.19
Groups (i,j) |Yi-Yj|
1,2 1.91 3.9325 4.04 3.5025
1,3 1.25 2.6725 2.17 1.23
2,3 0.66 1.26 1.87 2.2725
Groups (i,j) W-|Yi-Yj|
1,2 -0.79182 -2.16056 -1.90816 -1.17681
1,3 -0.13182 -0.90056 -0.03816 1.095685
2,3 0.458179 0.511938 0.261844 0.053185  
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